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Cylindricines A-K [1-11], lepadifonnine [12] and fasicularin [13] are tricyclic ascidian
alkaloids exhibiting the perhydropyrrolo[2,1 :j]quinoline and perhydropyrido[2,1-j]quinoline
ring systems. The structural features and biological activity of these alkaloids make them ideal
targets for total synthesis.
The first aim of this project was to construct the azabicycles [111] and [112] that resemble the
spirocyclic core of these alkaloids. The synthesis began with the C ring intact and the
attempted construction of the B ring using Diels-Alder methodology. A key step was the
Eschenmoser coupling reaction between thiolactams [105] and [106] to give the vinylogous
amides [107] and [108]. All attempts to convert the vinylogous amides to the corresponding
dienes proved to be unsuccessful, due to the fact that the preferred site for deprotonation was ~
to nitrogen and not a to the carbonyl group. Due to time constraints we moved to our second
aim, the enantioselective synthesis of the B and C rings offasicularin [13].
Significant progress was made towards our second goal. (5S)-5-Hydroxytetrahydro-
2(lH)pyridinone [127], which represents the C ring of fasicularin, was successfully
synthesized in 5 steps from L-glutamic acid [113]. This lactam was O-protected with tert-
butyldiphenylsilyl group to afford (5S)-5-tert-butyldiphenylsilyloxy-2-piperidinone [114].
Thionation of lactam [114] gave the thiolactam [160]. Conjugate addition of this thiolactam to
methyl acrylate gave methyl 3-[(5S)-5- {[tert-butyl(diphenyl)silyl]oxy}-2-thioxotetrahydro-
1(2H)-pyridinyl ]propanoate [163], which underwent a Eschenmoser coupling reaction with
bromoacetone to gIve methyl 3-[(5S)-5-{ [tert-butyl(diphenyl)-silyl]oxy} 2-[(£)-2-
oxopropylidine]tetrahydro-2(1H)-pyridinyl]propanoate [164]. Unfortunately conversion of
[164] into the corresponding diene using KHMDS and TBSCI was unsuccessful. The reaction
conditions caused the cleavage of the methyl acrylate protecting group on nitrogen, affording
the secondary E-vinylogous amide [167]. This constituted an important serendipitous
discovery - methyl acrylate can be used to protect the nitrogen atom of enaminones and can be
removed by KHMDS to access secondary E-enaminones that are otherwise difficult to
synthesise. Another route pursued was to introduce the hexyl chain in the A ring of fasicularin
by means of an SN2 reaction between lactam [114] and mesylate [116]. The stereodefined (lR)-
1-(2-{[tert-butyl-(dimethyl)sily]oxy}ethyl)heptyl methanesulfonate [116] was successfully
x
synthesized in 5 steps from l-octyne [115]. Unfortunately the subsequent SN2 reaction with
lactam [114] failed when we using t-BuOK and THF and time constraints prevented us from
attempting this coupling reaction using alternative conditions.
CHAPTERl
An overview of ascidian alkaloids, a review of reported approaches towards the synthesis
J
of the cylindricines, lepadiformine and fasicularin, and aims of this project.
1.1 Introduction
The history of alkaloids is almost as old as civilization itself. I Humankind used drugs
containing alkaloids in potions, medicines, teas, poultices and poisons for 4000 years, yet no
attempts were made to isolate any of the therapeutically active reagents from the natural
material until the early nineteenth century.l Opium was the ftrst alkaloid to be isolated, from
the dried latex of the poppy Papaver somniferum in 1805.1 Cordell' s deftnition of alkaloids is
as follows: "True alkaloids are toxic; they show a wide range of physiological activity; they are
almost invariably basic; they normally contain nitrogen in a heterocyclic ring; they are derived
from amino acids; they are of limited taxonomic distribution, and they normally occur in plants
as the salt of an organic acid."l This deftnition is not completely deftnitive because not all
alkaloids contain nitrogen as part of a ring system and there has been an increasing number of
examples of the occurrence of alkaloids in animal, insects, marine organisms, and
microorganisms. l-4
A later deftnition of alkaloids proposed by Dewick is as follows: "Alkaloids are organic
nitrogenous bases found mainly in plants, but also to a lesser extent in microorganisms and
animals.',4 This definition is preferred because it does not restrict nitrogen to being present in a
heterocyclic ring. The word alkaloid was originally derived from alkali. l,3,4 The degree of
basicity of an alkaloid depends on its structure and the effect of other functional groups.
Marine natural product chemists have enjoyed unrivaled success in the discovery of unique
new compounds. However instead of just searching for new metabolites, the search has
become more applied; targeting compounds which exhibit pharmacologically useful biological
activities? It has been proven that marine organisms, especially invertebrates such as ascidians,
sponges, soft corals and molluscs, produce secondary metabolites that are unprecedented
within the terrestrial biosphere? A diverse array of biomedically relevant compounds have
been detected, including central nervous system membrane-active toxins, ion channel effectors,
2
anticancer agents, tumor promoters, antiviral compounds, anti-inflammatory agents and
metabolites which affect microfilament-mediated processes.
Ascidians in particular have become the target of natural product research. Ascidians are
marine benthic invertebrates belonging to the phylum Chordata and subphylum Tunicates.2,5-7
Ascidians are commonly referred to as tunicates, because their body is covered by a saclike
case or tunic. They are also referred to as sea squirts, because many species expel streams of
water through a siphon when disturbed?
There are roughly 2000 known species of tunicate.2 Adult ascidians are sessile filter feeders,
either solitary or colonial. They live in regions that are free from extensive waveshock, but
receive considerable freely flowing water. Solitary ascidians may be as small as lcm or up to
l5cm in length. Colonial ascidians are usually found encrusting rocks and may be extremely
thin and delicate or as thick as 5cm. Some ascidians have indefinite shape, thus the contraction
which causes a sea squirt to spray streams of water distinguish ascidians from other marine
invertebrates, like sponges and fresh coelenterates.2 The majority of the compounds produced
by ascidians contain nitrogen derived from amino acids and are known to possess interesting
biological activities.2,5,7-11
An interest in ascidian chemistry started as early as 1847.2 Unusual colour changes in ascidian
blood were observed upon exposure to air, when blood would turn from yellow-green to deep
blue, however attention has focused, more recently on ascidians because of the biological
activities of their metabolites. Between 1988 and mid-l992 an incredible surge of interest in
ascidian chemistry yielded approximately 165 new ascidian metabolites? Ascidian alkaloids
are divided into a number of nitrogenous metabolites. They include peptide metabolites,
polycyclic aromatic alkaloids, tryptophan-derived, lysine-derived, tyrosine- and phenylalanine-
derived metabolites. Some examples of alkaloids from the Clavelinidae and Nephteis ascidian
families are reviewed in the following section.
1.2 An overview of ascidian alkaloids
A number of structurally interesting alkaloids have been isolated from the Clavelinidae family
of ascidians. An unidentified Clave/ina species gave the novel pyrroloiminoquinone alkaloid,
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wakayin shown below. 12 Clavelina picta obtained in Bermuda gave quinolizidine alkaloids,
clavepictines A and B,13 together with indolizidine alkaloids, piclavines A, B and C. 14 The
same species from Venezuela gave the quinoliz~dine alkaloid, pictamine. 11 Ascidian Clavelina
lepadiformis and its predatory flatworm Prostheceraeus villatus obtained in the North Sea gave
the decahydroquinoline alkaloids, lepadin A, B and c. IS,16 Clavelina cylindrica from Tasmania
gave tricYclic alkaloids, cylindricines A_K.S,IO,17 Clavelina lepadiformis from Tunisia gave
another interesting tricyclic alkaloid lepadiformine9 which is structurally similar to the
cylindricines. From the Micronesian ascidian Nephteis fasicularis, a tricyclic alkaloid similar to
the cylindricines and lepadiformine, was obtained, namely fasicularin. 7 This section will give a
brief overview of the above-mentioned alkaloids and their biological activities. These alkaloids






Many polycyclic aromatic alkaloids have been isolated from ascidians. 12 Ascididemnin and 2-
bromoleptoclinidinone from the ascidians Leptoclinides and Didemnum were the first aromatic
metabolites to be isolated? Wakayin is the first example of a reported pyrroloiminoquinone
alkaloid to be isolated from an ascidian. Ireland and co-workers isolated this novel alkaloid
from an unidentified Clavelina species in 1991. 12 It was first isolated and characterized as its
trifluoroacetate salt. There has been no reported total synthesis of wakayin, although Cava and
co-workers 18 and Barret and co-workers l9 reported a synthesis ofwakayin model compounds.
Wakayin possesses a variety of biological activities. It exhibits in vitro cytotoxicity against the
human colon tumor line (HCTI16; ICso 0.5 Jlg/mL) and inhibition of topoisomerase 11





Clavepictine A : R = Ac
Clavepictine B : R = H
Me
Pictamine
Clavepictines A and B were isolated in 1991 by Cardellina II and co-workers from the
Bermudian ascidian Clavelina picta. 13 These alkaloids were the fIrst quinolizidine alkaloids to
be isolated from an ascidian. Momose and co-workers2o reported the fIrst total synthesis of
clavepictine A and B. There are, to date, fIve reported syntheses of clavepictines A and B.20-24
These quinolizidine alkaloids exhibit antibacterial and antifungal activities. They inhibit
growth of murine leukemia and hwnan solid tumor cell lines at concentrations less than 9
~g/mL (lCso = 1.8-8.5 ~g/mL) and effectively kill all cell lines at less than 25 ~g/mL (LCso =
10.1-24.7 ~g/mL).13,2o-24
Faulkner and co-workers independently isolated pictamine from the same ascidian Clavelina
picta, collected in Venezuela. 11 There is only one reported total synthesis of pictamine.22
Pictamine is the bis-nor analog of Clavepictine A bearing two less carbons in the side-
chain.2,I0,20,22 It also possesses antimicrobial and antifungal activities.2,1l A thorough study of







Indolizidine alkaloids were previously unknown from marine sources, although similar mono-
substituted indolizidines are characteristic secondary metabolites found in the skin of
dendrobatid frogS. 14 Three series of indolizidine alkaloids (piclavines A, B and C), were
isolated by Cardellina II and co-workers from the Bermudian ascidian Clavelina pieta, in 1992.
14 Piclavine A was the first indolizidine alkaloid to be isolated in the marine biosphere. Each
piclavine differs in the number of double bonds in the undecyl substituent. Each piclavine is
composed of an inseparable mixture of isomers, which differ in stereochemistry at the Cs chiral
center (indolizidine numbering) and at each of the double bonds in the substituent. There are
two reported syntheses of piclavine A.25,26
It was found that these compounds serve as antifouling or antiinfective agents for both
tunicates and frogS. 14 These alkaloids are the principal antimicrobial agents of the ascidians.















The decahydroquinolines represent one of the major classes of amphibian alkaloids. Recently
these alkaloids have been found in the extracts of virgin queen myrmicine ants.27 Lepadin A
was the fIrst decahydroquinoline alkaloid to be isolated from an ascidian. Lepadin A was
isolated by Steffan in 1991 15 and lepadin B and C were later isolated by Andersen and co-
workers16 from the same ascidian, C/avelina /epadijormis, collected from the island of
Hegoland in the North Sea C/avelina lepadijormis is a colonial ascidian living mainly at
depths between 4 and 25m on sunlit submarine rocks and soils. Their tunic is absolutely
transparent allowing one to view the intestine. 15 The flatworm Prostheceraeus villatus is found
seasonally in the North East Antlantic Ocean and in the North Sea. Many of these flatworms
were found feeding on the tunicate Clavelina /epadijormis. Lepadin A, B and C were isolated
from both the predatory flatworm Prostheceraeus villatus and its tunicate prey Clavelina
lepadijormis. 16,28 There is one reported synthesis of lepadin A,27 four for lepadin B27-30 and one
for lepadin c.27
Lepadin A and B showed significant cytotoxic activity towards a variety of murine and human
cancer cell lines; murine leukemia (P338), human breast cancer (MCF7), human
glioblastoma/astrocytoma (U373), human ovarian carcinoma (HEY), human colon (LOVO)




In this section the spiro-tricyclic ascidian alkaloids exhibiting the perhydropyrrolo[2,1-
,
j]quinoline and perhydropyrido[2,1 :i]quinoline ring systems will be discussed. Why an interest
in these alkaloids? These are new structural classes of alkaloids, exhibiting some interesting
biological activities. Their structural features make them ideal targets for total synthesis. The
generic structure of these ring systems is shown below.
perhydropyrrolo[2,I-j]quinoline perhydropyrido[2,1:i]quinoline
Cylindricines A [1], C-I [3-9] and K [11] as well as lepadiformine [12] are based on the
perhydropyrrolo[2,1:i]quinoline structural motif while cylindricines B [2] and J [10] as well as










Blackman and co-workers isolated eleven cylindricine alkaloids (A-K) from the Tasmanian
ascidian Clavelina cylindrica in 1991.5,10,17 They ftrst isolated cylindricines A and B,IO which
were the first examples of perhydropyrrolo[2,1:i]quinoline and perhydropyrido[2, 1:/1quinoline
alkaloids from an ascidian. High resolution mass spectrometry (HRMS) indicated that the
molecular formula of the two alkaloids is the same CI9H32CINO, thus they are isomeric
alkaloids. The spectral data helped to elucidate the structures of the two compounds. NMR
spectroscopic analysis revealed that cylindricine B had the chlorine atom attached to a methine
8
group while cylindricine A possessed a CH2CI group. Single crystal analysis helped to resolve
the structures. It was found that a solution of cylindricine A [IJ or B [2J both gave, after 6
days, the same equilibrium mixture of 3:2 of cylindricine A and B. Thus the two alkaloids are
. 'bl 56mterconvertl e.'
R
o Cylindricine C : R = OH [3J
Cylindricine D : R = OMe [4]
Cylindricine E : R = OAc [5]




Further material yielded the minor alkaloids cylindricines C_G.5 HRMS together with infrared
(lR) and NMR spectroscopy revealed that cylindricines C-G were tricyclic tertiary amines with
a perhydropyrrolo[2,1-j]quinoline skeleton similar to cylindricine A. Cylindricine C has a
hydroxy group, cylindricine D has a methoxy group, cylindricine E has an acetoxy group and
cylindricines F and G have a thiocyanate group. Cylindricines F and G are the first
thiocyanates to be isolated from an ascidian. Cylindricines F and G are very similar in
structure; the only difference is the length of the alkyl side chain; cylindricine F has a n-hexyl
chain (C6H13) while cylindricine G has a n-butyl chain (C.JI9).
",OAc
R
Cylindricine H : R = SCN [8]








Four more alkaloids, cylindricines H-K., were isolated; 17 these were related to cylindricines A-
G previously isolated. Their skeletons are similar to either cylindricine A or B, differences
being the substituents and oxidation levels. HRMS showed that cylindricines H-J were
isomeric, with the molecular formula C20H32N202S. They posses an-butyl (C,J-I9) side chain
instead of a n-hexyl (CJI13) side chain. Cylindricine H has a thiocyanate group like
cylindricines F and G, while cylindricines I and J possess an isothiocyanate group.
Cylindricines H and I have the cylindricine A skeleton and cylindricine J has the cylindricine B
skeleton. The isothiocyanate group in cylindricine J is attached to a methine group rather than a
methylene group. The major difference between cylindricines H-J and previously reported
cylindricines is the replacement of the ketone functionality with an acetoxy group. Cylindricine
K is unique in that it possesses a cyclohexenone ring. Snider and Liu31 reported the first
synthesis of (±) cylindricine A [1], D [4] and E [5]. Heathcock and Liu6 reported the synthesis
of (±) cylindricine A [1] and B [2]. Molander and Ronn32 reported the first enantioselective
synthesis of (-)-cylindricine C (-)-[3].
The cylindricines exhibit bioaetivity against brine shrimp in a biomass and a DNA-repair-









In 1994, Biard and co-workers isolated lepadiformine from a Tunisian ascidian Clave/ina
lepadijormis.
9
Its structure is similar to the cylindricines isolated from Clavelina cylindrica.
Weinreb and co-workers
33
,34 and Kibayashi35 reported the first synthesis of the proposed
10
original structure of lepadifonnine [12']. They found that the synthetic material was different
to the natural lepadifonnine. Pearson and co-workers then synthesized the remaining three
diastereomers at C2 and CB, however none of these compounds were found to be identical to
the natural alkaloid.36,37 Thus the original structure of the alkaloid had to be revised to be
epimeric at the quaternary carbon and at C2 thus constituting the trans-fused perhydroquinoline
ring system. Kibayashi and co-workers reported the first synthesis of the revised structure of





Fasicularin is a novel marine tricycIic alkaloid isolated from the Micronesian ascidian Nephteis
jasicu/aris. Its structure was reported in 1997 by Patil and co-workers.7 Fasicularin possesses a
perhydropyrido[2,1-.Jlquinoline ring system and is thus structurally similar to the cylindricines
and lepadifonnine. Little work has been done on this alkaloid. There are, to date, two reported
syntheses of (±) fasicularin [13].8,38 Fasicularin has selective activity against a DNA repair-
deficient organism and is cytotoxic to Vero cells with an ICso of 14 J..lglmL.7 In the following
section the approaches of other workers to assemble the spirocyclic core of the cylindricines,
lepadifonnine and fasicularin are reviewed.
1.3 Reported syntheses of the cylindricines, lepadiformine and fasicularin.
The unique structure of these alkaloids as tricyclic systems which contain an azaspirocycle,
and their interesting biological activities make them ideal targets for total synthesis. Their
limited distribution in nature poses a challenge to organic chemists to synthesize more material
to enable extensive biological tests to assess the bioactivity of these fascinating natural
11
products. Several approaches to the construction of these azatricyclic ring systems have been
reported.
Snider and Liu31 reported the synthesis of (±) cylindricine A [1], D [4] and E (5). Heatbcock
and Liu6 reported the synthesis of (±) cylindricine A [1] and B [2]. Molander and Ronn32
reported the first enantioselective synthesis of (-)-cylindricine C (-)-[3]. There has been no
reported total synthesis or approaches to the synthesis of cylindricines F-K. Oppolzer with
Bagley39 in one paper, and with Bochet40 in another paper, reported the asymmetric synthesis
of the spirocyclic core of lepadifonnine and the cylindricine alkaloids. Weinreb33,34 and
KibayasbeS reported the first total synthesis of the putative structure of lepadiformine [12'J
while Pearson and co_workers36,37 reported the synthesis of the remaining three stereoisomers
at C2 and C13. Kibayashi and co-workers8 reported the first synthesis of the revised structure
of lepadiformine (±)-[12] as well as the first synthesis of fasicularin (±)-[13]. This section will
review the approaches of these workers to the synthesis of cylindricines A-E [1-5),
lepadiformine [12] and fasicularin [13]. We are primarily interested for the purpose of this
project in how these workers achieved the construction of the azaspirocyclic core of these
alkaloids.
Snider and Liu published the first total synthesis of cylindricines A [1], D [4J and E [5J in
racemic form, in 1997.31Cylindricine A [1 J was synthesized in 7 steps and in 5% overall yield
(Scheme 1.1). The most important feature in their route is the double Michael addition of NH3
to the dienone [18J to give the piperidinone [21] as one of the products. The first step was the
Grignard addition of 3-butenylmagnesiurn bromide to the acetal ketone [14J, followed by
hydrolysis of the acetal and dehydration to give the cyclohexenecarboxaldehyde [15J. Addition
of l-octynyllithiurn to the aldehyde [15J gave the alcohol [16], which was further reduced with
LAHlNaOMe
31
,41 to give alcohol [17J. Alcohol [17J was very unstable and underwent allylic
rearrangement on chromatography. Thus crude allylic alcohol [17J was oxidized by Mn02 to
give the divinylketone [18J. The double Michael addition of NH3 to the divinylketone [18J
afforded 47% of piperidinone [21J, and its two isomers, 9% of [19J and 34% of [20J.
Piperidinone [21J was reacted with N-chlorosuccinimide to give N-chloropiperidinone [22J.
The step of paramount interest for this project is the final radical cyclization to create the































Scheme 1.1 (i) (a) C~7MgBr, Et20; (b) HCl, heat, 60%; (ii) LiC=i:Cd!J3, THF, 64%; (iii)
LAH, NaOMe, THF; (iv) Mn02, CH2Ch 71%jrom /16}; (v) NH3, H2o' MeOH, NH4Cl, 65~,
47%; (vi) N-ehlorosuecinimide, CH2Ch 86%; (vii) CuCl, CuCh THF, AeOH, H20, 41%;
(viii) NaOMe, MeOH, 32%; (ix) NaOAc, MeOH, 91%.
Radical cyclization of N-chloropiperidinone [22] using CuCl and CuCh afforded the (±)-
cylindricine A [1). Treatment of (±)-cylindricine A [1) with NaOMe in MeOH resulted in the
formation of (±)-cylindricine D [4). Treatment of (±)-cylindricine A with NaOAc in MeOH
afforded cylindricine E (5).
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Heathcock and Liu reported the total synthesis of (±)-cylindricine A [I] and B [2], in 11 steps
and in 190.10 overall yield (Scheme 1.2).6 The characteristic feature of this route is the Stella's
metal-coordinated radical cyclization to furnish the spirofused ring (step xi). The first step was
,
the conversion of ~-trif1uoromethanesulfonyloxyester (23) into ~-substituted ester using the






















Scheme 1.2 (i) CH2CHCH2CH2CU(CN)Li, £t20; (ii) LiCH2P(0)(OMeh, THF, 95%; (iii) NaN,
(CHO)n, benzene, 86%; (iv) NH3-sat. EtON, cone. NH40N, 97%; (v) ClC02Me, K2C03,
CH3CN; (or) TFAA, £t~, CHJCh; (or) TEOC-Osu, K2C03, CH3CN, 81-96%; (vi), LDA,
TIPSTf THF, 89-97%; (vii) CAN, DMF, 90-95%; (viii) C~13MgBr, CuBr·Me2S, BF3'OEt2,
THF, 77-900,/0; (ix) TBAF, THF; (x) N-ehlorosuecinimide, CH2CiJ, 97%; (xi) CuCl, Cuel2,
THF, H20, AeON, 85%.
The ~-substituted ester was subsequently converted into the ~-ketophosphonate [24] using the
lithium anion of dimethylmethylphosphonate [LiCH2P(O)(OMe)2]. Homer-Emmons reaction
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with a l3-ketophosphonate [24J and paraforma1dehyde gave the divinylketone [25] in an
excellent 86% yield. Double Michael reaction on the divinylketone [25J afforded the
octahydroquinolinone [26J. Nitrogen protection of the octahydroquinolinone [26J using
ClC02Me or IFAA or TEOC-Osu gave the compounds [27aJ, [27b] and [27c], respectively.
The next step was enolate formation and the subsequent trapping of the enolate as its
triisopropylsilyl enol ether [28]. Ceric ammonium nitrate oxidation of the triisopropylsilyl enol
ether [28J afforded the vinylogous amide [29J.6,42,43 The hexyl side chain was introduced by the
conjugate addition of the cuprate formed by CJ-I13MgBr, CuBr·Me2S and BF3·OEt2 to the
vinylogous amide [29J to give carbamate [30].6,44,45 Treatment of the carbamate [30cJ with
IBAF gave the desired free amine [31]. Attempted nitrogen deprotection of the other
carbamates [30aJ and [30bJ failed; only the starting material was recovered. Treatment of the
amine [31] with NCS afforded the N-chloroamine [32]. Stella's metal-eoordinated radical
cylization6,46,47 of N-chloroamine [32J using CuCI and CuCh in aqueous acetic acid afforded a
mixture of cylindricine A and epi-cylindricine A. The two isomers were separated and
cylindricine A [IJ was allowed to convert to a mixture of cylindricine A [1] and B [2].
Molander and Ronn reported the first total synthesis of (-)-cylindricine C, in 11 steps with an
overall yield of 12%.32 The key feature of their route was the reduction of the azide [42]
followed by the double Michael addition to form the remaining two rings and three
stereocentres in one process (Scheme 1.3). The first step involved the selective protection of
the 1,2-diol moiety of 1,2,4-butanetriol [33], followed by the conversion of the remaining
primary alcohol into a tosylate [34]32,48 using tosyl chloride and Et3N. The tosylate (34) was
coupled with the enolate of cyclohexanone to give ketone [35J, this was followed by enolate
formation, and the subsequent trapping of the enolate as a silyl enol ether (36). The silyI enol
ether [36J was then converted into the corresponding enol triflate [37]. Palladium-catalyzed
Stille carbonylative coupling49,50 of the vinyl triflate [37) with (E)-trimethyl-I-octenylstanne
afforded the divinylketone [38J. Hydrolysis of the acetal gave the diol [39J, this was followed
by selective protection of the primary alcohol with the TBS group [40) and mesylation of the
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Scheme 1.3 (i) (a) Cyclohexanone dimethylhydrazone, LDA then /34/, THF; (b) Cu(OAeh
THFIH20, 77%; (ii) (a) (i-PrhNMgBr, Et20; (b) TMSCl, Et3N, HMPA; (iii) MeLi, THF,
ThNPh, TMEDA, 86%/rom /35/; (iv) (E)-trimethyl-1-oetenylstannane, LiCl, Pd(PPh3h CO(g),
79%; (v) (a) PdCl2(MeCNh cat., MeCN:H20 9:1, 83%; (b) TBSCl, NEt3, DMAP, CH2CiJ," (c)
MsCl, NEt3; (vi) NaN3' DMF,60 'C, 86%/rom /39/; (vii) TBAF, THF, 45%.
The mesylate [41] was converted into the corresponding azide [42] using sodium azide. The
azide [42] had all the carbons required for the alkaloid. The second and the third ring were
formed in one process. Reduction of the azide to an amine using CrCb,6,51,52 followed by
double Michael addition reaction and deprotection of the primary alcohol gave (-)-cylindricine
C (-)-[3].
Bagley et aL 39 reported the asymmetric synthesis of the spirocylic core of lepadifonnine and

































Scheme 1.4 (i) CICe(CH2hCH=CH2, 0.2M in THF, 0.5M HCI; (ii) PDC, DMF, 74%; (iii)
CH2N2, £t20; (iv) (HOCH]j2, PPTS, PhH, 98%; (v) AIMeJ, toluene, 78%; (vi) NaHMDS,
THF, l-chloro-l-nitrosocyclohexane, conc. HCI, 80%; (vii) 0.01M of/49/, toluene, 8; (viii)
Zn, AcOH/H20 (1:1), 53%.
The key feature of this route (step vii, Scheme 1.4) and the next route (step ix, Scheme 1..5),. is
the intramolecular nitrone/diene dipolar cycloaddition, which results in the fonnation of the
spirocyclic compounds [50) and [58), respectively, key intermediates to lepadiformine and the
cylindricines. The synthesis in Scheme 1.4 begins with the four step synthesis of acetal [47]
from 8-valerolactone [43]. The first step involved the addition of 6-hex-1-enylceriwn(III) to b-
valerolactone [43] to give the undecenol [44]. Oxidation of undecenol (44) with pyridinium
dichromate gave undecenoic acid [45]. Esterification and acetalisation of the keto-acid [45]
gave the acetal, methyl undecenoate [47]. Acylation of (2R)-bomane-1O,2-sultam with methyl
undecenoate [47] gave acylsultam [48]. Deprotonation and subsequent trapping of the enolate
with 1-chloro-l-nitrosocyclohexane followed by the acid catalysed hydrolysis of the acetal
resulted in the formation of the nitrone [49]. Reflux of nitrone [49] in toluene resulted in the
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fused tricycle [50] and bridged cyclo product [51], in 41% and 47% yield, respectively. N-O
bond cleavage of the fused cycloadduct [50] using acetic acid and zinc metal gave 1-
azaspiro[4,5]decane [52], an intermediate to the cylindricines and lepadifonnine.
Oppolzer and co-workers40 also reported an asymmetric synthesis of the spirocyclic core of
the cylindricine-type alkaloids, slightly different to the route depicted in Scheme 1.4.
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Scheme 1.5 (i) CdiJlMgBr, THF; (ii) (HOCH2J2, PPTS, PhH, 87% from {53/; (iii) OJ,
MeOH, Me2S, 89%; (iv) CBr4, PPh3, Zn, CH£h 66%; (v) AIMeJ, toluene, 68%; (vi) t-BuD,
TMSCI, 63%; (vii) NaHMDS, THF, l-chloro-l-nitrosocyc!ohexane, cone. HCI, 62%; (Viii)
Ni2B-BER, H2, MeOH, 43%; (ix) PhH, heat, O.OlM, 62%; (x) HF-pyridine, CH2Ch
In this route there is a selective formation of only the fused cycloadduct [58] with no traces of
the bridged cycloadduct [51] (Scheme 1.5). The spirocyclic compound [58] (Scheme 1.5) was
synthesized in 9 steps with an overall yield of 5%. The synthesis begins with the four step
preparation of dibrominated compound [54] from glutaric acid cWoride monoester [53].
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Addition of 5-hexenylmagnesium bromide followed by the ketone protection afforded the
acetal [47]. Ozonolysis of the tenninal olefm resulted in an aldehyde which was reacted with
CBr4 and PPh3 to give vinyl dibromide [54]. Acylation of the (2R)-bomane-l0,2-sultam with
compound [54], followed by the addition of t-BuLi and TMSCl gave the alkynylsilane [55].
Enolate fonnation using NaHMDS and the subsequent trapping of the enolate using l-chloro-
l-nitrosocyclohexane followed by the acid-catalysed hydrolysis of the acetal gave a single
diastereomer of the nitrone [56]. Partial reduction of compound [56] with nickel boride
borohydride resin (Ni2B-BER) gave the (Z)-vinylsilane [57]. Heating of (57] in benzene under
reflux gave exclusively the spirocyclic product, isoxazolidine (58]. The isoxazolidine [58] was
converted into the aldehyde (59], an intennediate to the cylindricines and lepadifonnine, upon
treatment with HF-pyridine. lIDs route showed the accessibility of the spirocyclic core of
cylindricines and lepadifonnine by a stereo- and regio-selective 1,3-dipolar cyloaddition
reaction.
Weinreb and co-workers reported the first synthesis of the putative structure oflepadifonnine
in a communication33 and later in a full paper34 (Scheme 1.6). Lepadifonnine [12'] was
synthesized in 15 steps with an overall yield of 5%. The most important feature of their route
is the intramolecular dipolar cycloaddition [67]---+[68] to fonn the spirofused core of
lepadifonnine. The synthesis began with the fonnation of (E)-oxime alcohol [62] from acetone
oxime [60] and epoxide (61]. Subsequent regiospecific alkylation of oxime [62] with
C6HI3CH=CHCH=CH(CH2)31 afforded compound [63]. The next step was the conversion of
the oxime (63] to ketone (64]. Protection of the secondary alcohol using a TBDPS group,
followed by acetalisation of the ketone afforded the silyl ether acetal [65]. Removal of the silyl
protecting group, oxidation of the resulting alcohol to the corresponding ketone, fonnation of
the oxime and subsequent hydride reduction of the oxime afforded the hydroxylamine [66].
Dilute hydrochloric acid was used to convert the hydroxylamine (66) into nitrone [67J. Nitrone
[67] was cyclized thennally to give isoxazolidine [68]. N-O bond cleavage of the isoxazolidine
[68] using acetic acid and zinc gave amino alcohol [69]. Three additional steps completed the
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Scheme 1.6 (i) n-BuLi, THF, /61J 86%; (ii) n-BuLi, THF, CJf13CH=CHCH=CH(CHJ)31,
76%; (iii) riCh NH40Ac, H20lHOAc (1:1), dioxane, 86%; (iv) (HOCHJ)2, p-TsOH, PhH,
reflux, 97%; (v) TBDPSCI, imidazole, CH2Ch, 92%; (vi) TBAF, THF, 99%; (vii) DMSO,
CH2Ch 93%; (viii) NH20H-HCI, pyr, EtOH, 100%; (ix) NaBH3CN, 2N HCI, MeOH, 95%; (x)
3N HCI, THF, 92%; (xi) DMSO, 190CC, 63%; (xii) Zn dust, HOAc, 91%.
Pearson and co-workers reported the syntheses of the three remaining diastereomers of the
putative structure of lepadifonnine in both a communication37 and a full paper.36
Lepadifonnine was synthesized in 10 steps with an overall yield of 0.4% (Scheme 1.7). The
important step in this route is the formation of the spirofused compound [77] by reacting
stannylimine (76) with n-BuLi and phenyl vinyl sulfide. The synthetic route began with a five
step synthesis of 2-[2-(2-methyl-I,3-dioxonal-2-yl)ethyl]cydohexanone [74] from
cyclohexanone [70). The first step was the preparation of the ketoester (71) from cylohexanone





















Scheme 1.7 (i) (a) p-TsOH, pyrrolidine, -H20; (b) ethyl acrylate, H20, 91%; (ii) Zn, PbCh
TiCI4, CH2Br2, 61%; (iii) Me2AIN(OMe)Me, C6H13MgBr, 73%; (iv) (HOCH])2, TMSCI, PhH,
84%; (v) 0 3, CH2Ch NaHC03, MeOH, 45%; (vi) AIMe3, PhH, O'C; (vii) n-BuLi,
CH2=CHSPh, H20, 41% from [74j.
This was followed by the methylenation of the ketone to give the ester [72J. The ester was
converted into the ketone [73] using Me2AIN(OMe)Me and C6H13MgBr. Carbonyl protection
and ozonolysis of alkene [73] afforded the ketone [74J. The ketone [74] was condensed with
the amine [75], to give the stannylimine [76]. Without purification, treatment of the imine [76)
with phenyl vinyl sulfide and n-BuLi afforded the spirofused azabicyclic compound [77]. Tin-
lithium exchange of stannane [76] with n-BuLi produced the 2-azapentadienyl anion, which
participated in a [1t4s + 1t2s] cycloaddition reaction with phenyl vinyl sulfide to afford the
spirocylic pyrrolidine [77].37 Three more steps led to the total synthesis of 2,13-
diepilepadifonnine [12") or 2-epi-II-deoxycylindricine C. Pearson used the same
methodology to synthesize the remaining two of the four diastereomers of lepadifonnine.
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Kibayashi and co-workers35 reported a stereocontrolled approach to the proposed structure of










































Scheme 1.8 (i) PrJVI04, CHCiJ, 9,lO-dimethylanthraeene, 84%; (ii} benzene, reflux, 75%; (iii}
H2, Pd-C, Et~ MeOH, 63%; (iv) Na(Hg), Na2HP04, EtOH, 97%; (v) MsCl, 2,4,6-coIlidine,
NaOH, THF-MeOH, 65%; (vi) NaH, THF, 87%; (vii) MOMC1, i-Pr2NEt, 93%; (viii) (a)
BHJ,NHJ, BuLi; (b) CbzCl, Na~03, 78%; (ix) (a) DMSO, (COClh, £t~ CH2CI2; (b)
CJfllMgBr, £t20; (e) pec, CH~h 66%.
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The first important feature is the intramolecular hetero Diels-Alder reaction of [80).35 The
second important step is the treatment of lactam [85] with NaB in refluxing THF causing the
regioselective formation of the five--membered spirofused compound [86]. Their route begins
with the four step synthesis of hydroxamic acid [79] from the cyclohexanone derivative [78].
Oxidation of the hydroxamic acid [79) in the presence of 9,IO-dimethylanthracene gave
compound [80). Compound [80] underwent intramolecular cylisation to give the tricyclic
diastereomeric mixture of eis product [81] and trans product [82) in a 5.5:1 ratio. Catalytic
reduction of the two diastereomers gave only the eis-fused isomer [83]. Reductive cleavage of
the N-O bond gave the diol [84]. The diol [84] was converted into the epoxide [85] via
selective mesylation of the primary alcohol followed by treatment with alkali. Intramolecular
cyclization with concomitant epoxide ring opening gave the tricyclic compound [86].
Compound [86] underwent lactam ring opening, followed by N-protection to give the alcohol
[88]. Swern oxidation of alcohol [88] followed by Grignard reaction with C6HlIMgBr, and
PCC oxidation gave the ketone [89]. Catalytic hydrogenation of the ketone [89] and removal of
the MOM protecting group gave lepadiformine [12'].
Kibayashi and co-workers also reported the first total synthesis of (±)-lepadiforrnine (±)-[12]
and (±)-fasicularin (±)_[13].8 The preliminary steps towards the synthesis of the two alkaloids
were the same. Scheme 1.9 shows the route to the synthesis offasicularin [13], in 25 steps with
an overall yield of 2%. The most important feature in the synthesis of fasicularin (13] is the
intramolecular acylnitroso-Diels-Alder reaction of diene [91], which prefers formation of the
trans-product [92]. Tricyclic compound [92] was transformed into lactam [94] in 7 steps.
Another important step is the conversion of lactam [94] into the spiro tricyclic compound [95],
using NaH in refluxing THF. Lactam [95J was converted into tricycle [96] in 6 steps. The last
reaction was the Mitsunobu condensation with thiocyano acid, which proceeded with complete


















Scheme 1.9 (i) Pr.,N104, H20-MeOH (5:1), 84%; (ii) NaR, THF, reflux, 99%; (iii) HSCN,
Ph3P, DEAD, benzene, 20%.
Furthennore, Kibayashi and co-workers reported the fIrst total synthesis of lepadiformine (±)
[12J, in 22 steps with an overall yield of 4% (Scheme 1.10).8 Diketone [90] was transfonned
into azatricycle [97] in 12 steps. Azatricycle [97J underwent reductive N-O bond cleavage
followed by mesylation of the secondary alcohol, to provide mesylate [98]. Base treatment of
mesylate [98J led to the fonnation of the third ring of spiro-fused tricyclic compound [99J. Six
further steps resulted in the fonnation of (±)-lepadiformine (±)-(12]. Treatment of (±)-(12] with
methanolic Hel resulted in the fonnation of hydrochloride salt (100]. The NMR data of (±)-





















Scheme 1.10 (i) t-BuOK, THF, 91%; (ii) 1N He/-MeOH
matched those of the isolated material. Thus lepadifonnine was isolated as its hydrochloride
salt (this is understandable because the isolation of the natural alkaloid was achieved by
evaporation of an acidic solution [MeOH-IN HCI 99:1] of the chromatography fractions).8 In
the next section the specific aims of this project will be presented.
1.4 Aims
The first aim of this project is the development of methodology for the construction of model
compounds that resemble the spirocyclic core of the cylindricine-like compounds (Scheme
1.1l). Thus spirocycle (111] will serve as a model for cylindricines A (1], C-I (3-9] and K (11]
as well as lepadiformine (12] while spirocycle (112] will serve as a model for cylindricines B
(2] and J (10] as well as fasicularin (13]. Inspection of our approach will show that it is
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The major goal is the preparation of the azaspirocycles [111J and [112J. The first step involves
the preparation of the thiolactams [105J and [106J, from 2-pyrrolidinone [101J and 2-
piperidinone (102), by N-methylation using sodium hydride and iodomethane (step A) and the
thionation of the carbonyl group using Lawesson' s reagent (step B). As these are model studies
we chose the simplest alkyl group, namely methyl, for nitrogen. I-Methyl-2-pyrrolidinone
(103) is commercially available so there is no need for the N-methylation of 2-pyrrolidinone.
Transformation of the thiolaetams (105) and [106] into the corresponding vinylogous amides
[107] and [108J is accomplished by using the Eschenrnoser coupling reaction53 between the
thiolactam and bromoacetone (step C).
Vinylogous amides are versatile intermediates that combine the ambidient nucleophilicity of
the enamine with the ambidient electrophilicity of enones (Figure 1).54,55 The enamine
nucleophilicity at the nitrogen and carbon can be extended to the carbonyl oxygen atom by
conjugation (structures A-C). In addition, deprotonation with a strong base can provide an
additional nucleophilic site Pto nitrogen (structure D). The systems also have enone character

















The next step (step D) is to convert the vinylogous amides [107) and [108], into the dienes
[109] and [110] by enolate fonnation followed by the subsequent trapping of the enolate as the
corresponding enol ethers. The fmal step (step E) is the construction of the B ring using the
Diels-Alder reaction between the dienes [109] and [110] and a suitable dienophile to give the
azaspirocycles [Ill] and [112].
Over the 70 years since its report by Diels and Alder, the synthetic potential of the Diels-Alder
reaction has been greatly expanded through modifications of the diene and dienophile
components.58 The hetero Diels Alder reaction has emerged as a method of choice for the
stereocontrolled synthesis of six-membered heterocycles, which are building blocks for a wide
range of natural products.59 The Diels-Alder reaction can produce from one to as many as four
stereocenters in a single step. Thus in step E we intend to use the Diels-Alder reaction between
the dienes [109] and (110] and phenyl vinyl sulfone as dienenophile to assemble the Bring.
Once the first aim is achieved the synthesis will then be repeated using a modified C ring so as
to incorporate the thiocyanate moiety in fasicularin [13]. The second aim is thus to develop a
novel stereoselective route towards the synthesis of fasicularin. Taking the time constraints of a
Masters project into account, we realistically intend to construct only the B and the C rings of
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fasicularin using this route. Fasicularin was chosen in particular because at the beginning of
this project (early 2000) there was no reported synthesis of this fascinating alkaloid. Scheme
1.9 shows the first reported total synthesis of fasicularin [13) by Kibayashi and co-workers. 8
Their route has a large number of steps (25) and is linear in design. Our route is convergent and
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(5S)-5-Tert-butyldiphenylsilyloxy-2-piperidinone [114), which constitutes the C ring of
fasicularin, is synthesized in 6 steps from (S)-glutamic acid (113].60-62 Mesylate (116] is
synthesized from l-octyne [115] in 5 steps63 Lactam [114] and mesylate [116] are then
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coupled (step A) to give N-alkylated lactam [118aJ. Alternatively, lactam [114) can be added
conjugatively to enoate [117J to give N-alkylated lactam [118bJ. Methyl-2-nonenoate [117J is
synthesized from methyl bromoacetate and heptanal using the Wittig reaction. The amide
carbonyl is thionated (step B) to give the thiolactam [119J. The next reaction (step C) is the
Eschenmoser coupling of the thiolactam [119) with bromoacetone, to give the corresponding
vinylogous amide [120J. The ftnal steps, which complete the B ring of fasicularin (steps D and
E), are the diene [121] formation and the Diels-Alder reaction between the diene and an
appropriate dienophile to give azaspirocycIe [122].
What precedents can we draw on in support of the proposed synthetic route outlined in Scheme
1.12? Many of the steps have literature precedents. The following step-by-step analysis gives
an account of both the encouraging features and the potential problems that are expected in the
proposed route.
Synthesis of (5S)-5-tert-butyldiphenylsilyloxv-2-piperidinone [114/: Literature precedent for
the synthesis of (5S)-5-hydroxy-2-piperidinone [127] from L-glutamic acid [113] is found in
the publications by Herdeis,6o Silverstein61 and Thompson,62 therefore no problems are
expected (Scheme 1.13). In this manner (S)-glutamic acid [113J is converted into (5S)-5-
hydroxy-2-piperidinone [127] in an overall yield of 24% (Scheme 1.13). The fIrst step is the
transformation of (S)-glutamic acid [122] into the corresponding lactone [123] using
hydrochloric acid and sodium nitrite. Lactone [123] is reduced to primary alcohol [124] using
the borane-methyl sulfide complex. Treatment of the alcohol [124] with methane
sulfonyIchloride and triethylamine gives the mesylate [125J. Heating of the mesylate [125J
with NaN3 affords the azide [126]. Hydrogenation of the azide [126] yields (5S)-5-hydroxy-2-
piperidinone [127]. The next step requires the selective protection of a secondary alcohol in the
presence of a secondary amide and is potentially problematic. The protecting group could go to
the secondary alcohol and/or the secondary amide. Thus we need to find a chemoselective
method. However Herdeis and co-workers64 reported the selective protection of the OH group
in (5S)-5-hydroxy-2-piperidinone [127], using TBDPSCl and imidazole in DMF to give lactam
[114]. We intend to use the same method.
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Scheme 1.13 (i) NaN02, HCI, H20, 55%; (ii) HJI3 S(CH3h, THF, MeOH, 72%; (iii)
CH3S02CI, Et~, CH2Ch 88%; (iv) NaN3, 18-crown-6, CH3CN, 93%; (v) H2, Pd-C, MeOH,
300 kPa, 77%; (vi) TBDPSCI, imidazole, DMF, 98%.
Synthesis o{(lR)-1-(2-fftert-butyl(dimethyl)silyloxvlethyl)heptyl methanesulfonate 1116/: 1,3-
Nonanediol [131] is synthesized in 4 steps from l-octyne [115] (Scheme 1.14).63
/ (i) /OH (ii) 4H13~OHCt>H13 ---. 4H13 (128) -----. (129)1115]
~ (iii)
OMs OH 0
Ct>H ~OTBS (v) Ct>HI3~OH (iv) Ct>H13~OH..-- ..--
13 1116) 1131) 113O)
Scheme 1.14 (i) EtMgBr, CH20, 86%; (ii) LiAIH4, 76%; (iii) (-)-DET, Ti(OPrh, TBHP; (iv)
Red-AI, 80%from 1129/; (v) Rei32.
The synthesis begins with the fonnation of2-nonyn-l-ol [128] by reacting l-octyne [115] with
ethyl magnesiwn bromide and formaldehyde. Reduction of alkyne [128] with LiAl.Ht yields
the allylic alcohol [129]. Sharpless epoxidation followed by reduction of epoxide [130) yields
(3R)-1,3-nonanediol [131]. Close inspection of compounds [131] and [116] in Scheme 1.14
reveals similarities with compounds [39] and [41] in Scheme 1.3. Thus mesylate [116] will be
synthesized from 1,3-diol [131] using the methodology reported by Molander.32
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Synthesis ofmethyl-2-nonenoate 1117/: Methyl-2-nonenoate [117] is synthesized from methyl
bromoacetate [132] and heptanal using the Wittig reaction (Scheme 1.15). Methyl
bromoacetate [132] is reacted with Ph3P to give the phosphorus ylide. The ylide reacts with
heptanal to produce a mixture ofE and Z isomers ofmethyl-2-nonenoate [117].







Step A: Literature precedent for the conjugate addition of the lactam [114] to methyl-2-
nonenoate [117] is found in the work of Michael and Gravestock.54,57,65-67 Michael and
Gravestock reported the conjugate addition of ethyl oct-2-enoate [l17b] to pyrrolidine-2-thione
in their work on the synthesis of alkaloids 209B isolated from the skins of dendrobatid frogs
(Scheme 1.16).65-67 They used a catalytic amount of sodium hydroxide as base and their yield






Scheme 1.16 (i) NaOH (cat), THF, rt.
We thus intended to use their method to form lactam [1l8b] from lactam [114] and methyl-2-
nonenoate [117]. This reaction is expected to produce a mixture of diastereomers of lactam
[118b] and subsequent separation of the desired stereoisomer may be difficult. To circumvent
this difficulty, it is hoped that an SN2 reaction between the lactam [114] and the stereodefined
mesylate [117] will give alkylated lactam [1188] as a single stereoisomer.
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Step B: Amides can be converted to corresponding thioamides using the Brillon method,68
Belleau's690r Lawesson's reagents.70 For our project we intend to use Lawesson's reagent
because the method is the simplest and does not require an aqueous workup. Lawesson's
,
reagent does the conversion selectively and efficiently, under mild conditions in the presence
of other functional groups including esters.53 Lactam [118] is heated at reflux with Lawesson's
reagent in toluene to give the corresponding thiolactam [119]. Only 0.6 equivalents of the
Lawesson's reagent are used because it has two sulfur atoms to donate. We can interchange
Steps B and A, however it is better to start with N-alkylation (step A) and then perform the
thionation (step B). Occasionally S-alkylation results during attempts to N-alkylate a secondary
thi 'd 71OamI e.
Step C: Conversion of thioamide into a vinylogous amide is easily achieved by use of the
Eschenmoser coupling reaction.53 Thiolactam [119] is coupled with bromoacetone to give the
vinylogous amide [120]. Bromoacetone is synthesized from acetone and bromine under
aqueous acidic conditions.72
Steps D and E: Rawal and co_workers58.59,73-77 have published a number of papers concerning
the preparation of 1-amino-3-siloxy-1 ,3-butadienes [134] and their subsequent participation in
Diels-Alder reactions (Scheme 1.17). These butadienes are formed by reacting the vinylogous
amide [133] with potassium bis(trirnethylsilyl) amide (KHMDS) followed by the subsequent
trapping of the enolate with a silylating reagent (TBSCI, TIPSCI or TBDPSCI). The dienes
[134] undergo the Diels-Alder reaction with various dienophiles [135J to form cycloadducts
exo-[136] and endo-[137], which can be separated. Dienophiles that have been used
successfully include methyl acrylate, methyl crotonate and acrylonitrile. Different ratios and
yields of the endo and exo products are obtained, depending on the dienophile and the solvent
used. For example methyl acrylate gave a 1.5: 1 ratio of exo:endo diastereomers and
acrylonitrile gave 4:1 ratio of exo:endo diastereomers. Toluene gave high yields compared to
THF and CH3CN. Close inspection of structures [120] and [121] in Scheme 1.12 will reveal
their similarity to compounds [133] and [134J. We thus intend to use this methodology for
steps D and E, to construct the B ring of fasicularin [13], using TBSCI to trap the enolate and
phenyl vinyl sulfone as the dienophile. Phenyl vinyl sulfone is chosen because the phenyl
sulfonyl group is easily removed from the resulting product [122], using sodium amalgam in
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R3Si = TBS, TIPS and TBDPS
Scheme 1.17
The following chapter will gIve an account of the successes and failures incurred when




This chapter will discuss the experimental findings for model studies towards the construction
of the azaspirocycles [111J and [112J (Scheme 1.11). The first section will describe the N-
methylation of piperidinone [102J and the thionation of lactams, 1-methyl-2-pyrrolidinone
[103J and 1-methyltetrahydro-2(lH)-pyridinone [104J. This will be followed by subsequent
sulfide contraction of the resulting thiolactams with bromoacetone to give the vinylogous
amides 1-(I-methyl-2-pyrrolidinylidene)acetone [107] and 1-( I-methyl-2-piperidinylidene)-
acetone [108J respectively. Attempted diene ([109J and [110]) fonnation, which on reacting
with the dienophile results in the fonnation of the azabicycles [111] and [112] will also be
discussed. Also to be included is the discussion of selected carbon and proton NMR
spectroscopic data of some of the compounds synthesized.












I-Methyl-2-pyrrolidinone [103] is commercially available so there is no need to synthesise it
from 2-pyrrolidinone [101]. However, 1-methyltetrahydro-2(lH)-pyridinone [104] needed to
be synthesised. N-Methylation of2-piperidinone [102J was achieved by reacting it with sodium
hydride and iodomethane in TIfF. Purification by column chromatography afforded pure 1-
methyltetrahydro-2(lH)-pyridinone [104J as a yellow oil in a 66% yield. The product was
continned by 'H and l3C NMR spectroscopy, and GCMS. Proton NMR spectral analysis of
the product shows a characteristic singlet peak at 2.9 ppm, corresponding to the three protons
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on the methyl group, methylene protons at C4 and Cs appeared as a multipiet from 1.7-1.9 ppm
and protons of the methylene groups C3 and C6 appeared as triplets at 2.4 ppm and 3.3 ppm
respectively. In the carbon NMR the characteristic carbonyl peak at 170 ppm was observed.
2.1.2 1-Methyl-2-pyrrolidinethione [105) and 1-methyltetrahydro-2(1H)-pyridinethione
[106]
Smith et al. 79 reported the synthesis of the two thiolactams [105] and [106] using Lawesson's
reagent. The structure of Lawesson's reagent is shown below. An alternative method
developed by Brillon can also be used for the thionation of amides.68 Brillon' s method mixes
phosphorous pentasulfide and sodium carbonate in THF to form a sodium salt and carbon
dioxide. The salt is then reacted with the amide in THF and after aqueous workup the desired
thiolactam is obtained. We decided to use Lawesson's reagent because with Lawesson's













Scheme 2.2 (i) Lawesson's reagent, toluene, 2h reflux.
I-Methyl-2-pyrrolidinone [103] and l-methyltetrahydro-2(l H)-pyridinone [104] were heated at
reflux with 0.6 equivalents of Lawesson's reagent in toluene for 2h. Purification by column
chromatography afforded l-methyl-2-pyrrolidinethione [105) and l-methyltetrahydro-2(1H)-
pyridinethione [106] in an overall yield of90% and 86%, respectively.
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The NMR spectroscopic data showed good correlation with the data reported by Smith et at. 79
2D NMR experiments (COSY and GHSQC) were performed to assign all the signals
unambiguously. Comparing lactam (104) and its corresponding thiolactam (106), the lH NMR
of (106) showed two clearly resolved multiplets corresponding to the C4 and Cs protons, yet
the two signals overlapped in the spectrum for the lactam [104J. In the carbon NMR spectrum
the absence of the carbonyl peak at 170 ppm, is an indication that reaction had taken place. A
new signal at 200 ppm which corresponds to a thiocarbonyl was observed. Unfortunately this
thionation reaction produces an unpleasant odour, thus it is important to work in the fume hood
at all times and to dispose of the residues properly by treatment with sodium hypochlorite
(bleach).
2.1.3 1-(1-Methyl-2-pyrrolidinylidene)acetone [107J and 1-(1-methyl-2-piperidinylidene)-
acetone [108J
Bromoacetone was prepared by the dropwise addition of bromine to a solution of acetone,
glacial acetic acid and water at 60°C.72 The resultant oil was distilled twice, since the first





Pure bromoacetone was obtained as a colourless liquid in 60% yield at 28-30°C (9m.mHg). The
distillation was performed at reduced pressure because the product decomposes at high
temperatures. Bromoacetone is a strong lachrymator and thus one has to take special care when
working with it. It also decomposes at high temperature, so it was prepared just before use in
the Eschenmoser coupling reaction to form the vinylogous amides and was stored in a freezer
between reactions.
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1-(l-Methyl-2-pyrrolidinylidene)propanone [107] and 1-(l-methyl-2-piperidinylidene)-
propanone [108] were prepared by the Eschenmoser coupling reaction between thiolactams
[105] and [106] respectively, and bromoacetone. The Eschenmoser coupling reaction is
composed of two steps, which are conducted in one pot. The fITst step is alkylation of sulfur to
form an iminium bromide salt, followed by extrusion of sulfur with a thiophile. Outlined in
Scheme 2.4 is the mechanism for this reaction as proposed by Shiosaki.53 Treatment of
thiolactams [105] and [106] with bromoacetone, results in the S-alkylated a-thioiminium salt
[138]. Secondly, treatment of the salt [138J with base (Et3N) and the thiophile (Ph3P) results in
the extrusion of the sulfur atom via the proposed episulfide intermediate [139J. Aqueous
workup followed by purification by column chromatography resulted in the formation of the
desired 1-(1-methyl-2-pyrrolidinylidene)propanone [107] and 1-(l-methyl-2-












The spectral data of our vinylogous amide [107] matched those reported by Michael and co-
workers.
8o
Proton NMR spectroscopic evidence of the fonnation of the vinylogous amide, 1-
(l-methyl-2-piperidinylidene)-acetone [108] was shown by the presence of two new singlets at
4.9 ppm and 1.9 ppm, corresponding to the methine (vinyl) proton and methyl protons a to the
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carbonyl. The carbonyl carbon appeared at 193 ppm in the carbon NMR spectra. The
disappearance of the thiocarbonyl peak at 200 ppm was further proof of the success of the
reaction. We are unable to rationalize why the six-membered ring thiolactam [106] gave poorer
,
yields than its five-membered analogue [105]. However, other solvents were investigated to try
and improve the yield of the vinylogous amide [108J, but without success.
In an attempt to fmd an alternative route to the synthesis of the vinylogous amide [108J a paper
by Sabitha and co-workers81 was discovered. This reaction is worth trying because it is one
step less than our initial route, and it would convert lactam [104J to a vinylogous amide [108J
avoiding an intermediate thionation step. Sabitha and co-workers81 reported the Wittig
olefination of lactones [140J and amides [144J under microwave irradiation (Scheme 2.5).
Triphenyl phosphine was reacted with ethyl bromoacetate to give the phosphorus ylide [141J.
The lactone [140] was reacted with the ylide [141J at 90°C in a microwave oven, giving
isomeric products [142J and [143J in an overall yield of 80%. A similar reaction was done on
the amide [144J giving products [145J and [146J in an overall yield of 86%. These reactions
were quick since they took less than 2 min. This method looked promising for the synthesis of
the vinylogous amide [108) from the lactam [104J.
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The above methodology was attempted by reacting the lactam [104] with the phosphorus ylide
[147] (synthesised from triphenyl phosphine and bromoacetone Scheme 2.6), but no matter
how long the reaction mixture was left in the microwave, there was no sign of any product
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being fonned. Different power settings (low, med, med-low, high) were tried, but the results









We then decided to persevere with the Eschenmoser coupling reaction using large quantities to
get more of the desired material. Thus a more efficient method is still required to improve the
low yield of this reaction.
2.1.4 Attempted preparation of dienes (109) and (110)
Having successfully synthesized the vinylogous amides 1-(1-methyl-2-
pyrrolidinylidene)acetone (107) and 1-(1-methyl-2-piperidinylidene)-acetone (108), the next
step was to convert them into their corresponding dienes. The first reaction attempted was the









Silylation was initially attempted using LDA and TMSCI at -78°C. The vinylogous amides
[107J and [108J were reacted with LDA followed by the subsequent trapping of the enolate
with a silylating reagent TMSCI (Scheme 2.8)..~e reaction did not work and starting materials
were recovered. Increasing the temperature and changing bases to sodium hydride (NaH) and
potassium hydride (KH) did not improve matters. Once again only the starting material was







Scheme 2.8 (i) (AcOh, p-TsOHlHCI04, K2C03.
Acylation using acetic anhydride (ACO)2 and p-TsOH, HCI04 or K2C03 as promoters, was
attempted based on literature precedents,82,83,84 but the results were similarly disappointing
(Scheme 2.8). The staring materials were recovered in each case.
2.1.4.3 Alkylation
O-Alkylation was attempted using NaH and ethyl iodide (Et!) in ether but without success as
only starting materials were recovered. Changing the solvent to DMF did not improve matters.
The base was then changed to KH and ether as the solvent, based on the reaction shown below
in Scheme 2.9 reported by Wenkert and Kunesch.85
Wenkert and Kunesch 85 in their work towards the synthesis of (±) aspidofractine, reported two
steps relevant to our synthetic work (Scheme 2.9). These steps were the synthesis of the diene
(149] from [148], and the Diets-Alder reaction between the diene (149] and methyl acrylate to






Vinylogous amide [108] was reacted with KH to form the enolate and this was followed by the
trapping of the enolate with ethyl iodide (Scheme 2.10). An excess of ethyl iodide was added














Scheme 2.10 (i) KH, Etl, THF, O°e.
GCMS data showed that the product formed had the expected mass, since the molecular
formula of the obtained and the expected products is the same, ClI H I9NO. IH and DC NMR
41
data, DEPT and 2D NMR experiments (COSY and GHSQC) however showed that the product
was not the desired diene even though it had the same mass. On observation of the carbon and
proton NMR it was clear that no change had occurred in the enone functionality of the
vinylogous amide. In the proton NMR the two singlets corresponding to the vinyl proton and
the methyl protons were present at 5.0 ppm and 2.8 ppm respectively. There were additional
signals showing that a reaction had taken place. From the DEPT spectrum we ascertained that
the product had three methyl groups instead of two and two methine carbons instead of one.
Instead of fonning the diene [110] the vinylogous amide, 1-(3-ethyl-l-methyl-2-
piperidinylidene)propanone [152] had been formed in a 92% yield. The ethyl group went to
the position p to nitrogen instead. This result is not altogether unexpected when one considers
the ambident reactivity of the enaminones depleted in Figure 1 (structure D, p. 26). Thus under
these reaction conditions the preferred site for nucleophilic reactivity is p to nitrogen. Why did
our reaction fail despite the literature precedent provided by Wenkert and Kunesch in Scheme
2.9? The major difference between our starting material and that reported by Wenkert and
Kunesch is that their p-position was blocked- i.e. this is a quaternary carbon and thus has no
proton available to abstract (Scheme 2.9). When repeating the same reaction on the vinylogous
amide [107] we obtained the same results, i.e. the ethyl group went to the carbon at the position
p to nitrogen instead of the oxygen atom to afford the vinylogous amide, 1-(3-ethyl-l-methyl-
2-piperidinylidene)propanone [151].
These results are interesting as they demonstrate that the preferred site for deprotonation is p to
nitrogen and not a to the carbonyl group.
<s cs: ~Me:~ (i) (i) +... • 0
(154] 1153] (155] (156]
Scheme 2.11 (i) LDA, -78°C, Me!.
·Il-posirion is indicated by an asterisk in Scheme 2.9.
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Rawal and co-workers experienced similar problems on their work towards the total synthesis
of perhydropyrrolo[2,IJlquinoline alkaloids (Scheme 2.11).86 From the vinylogous amide
[153], Rawal and co-workers intended to form the enolate and trap it with a methyl group to
form the diene [154]. Instead they discovered that the preferred position for alkylation was ~ to
nitrogen [155]. Compounds [155] and [156] were obtained in 74% and 9% respectively.
Variation of reaction conditions as well as the use of different bases, such as KHMDS, had
little effect on the ratio of [155] to [156].86
Figures 2 and 3 show the proton and carbon NMR spectra of 1-(3-ethyl-l-methyl-2-
piperidinylidene)propanone [152), respectively. In the proton NMR., the triplet at 0.92 ppm
corresponding to the methyl protons (Cl I) a to the methylene group (C IO) was observed, clear
evidence that the ethyl group had indeed been added to the starting material, unfortunately not
at the desired position. The presence of non-equivalent signals assigned to diastereotopic
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Figure 2 I H NMR spectrum of 1-(3-ethyl-l-methyl-2-piperidinylidene)propanone [152] in
CDCh
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In the carbon NMR spectrum the carbonyl carbon and the quaternary carbon a to nitrogen
resonate at 193 ppm and 168 ppm respectively. The vinyl carbon was observed at 93 ppm and
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Figure 3 13C NMR spectrum of 1-(3-ethyl-l-methyl-2-piperidinylidene)propanone [152]
inCDCh
The explanation for the failure of this O-alkylation reaction is the fact that there is more than
one set of acidic protons in the vinylogous amide and alkylation did not occur at the desired
position. We have been unable to fmd reaction conditions that favour formation of the required
diene.
2.1.4.4. Petasis methylenation
More attempts were made to synthesize the diene, this time using the Petasis methylenation.87
This method uses dimethyltitanocene (CP2TiMe2) for the methylenation of carbonyl
compounds including aldehydes, ketones and esters. Dimethyl titanocene is prepared from
titanocene dichloride and methyllithium. The Petasis methylenation reaction proceeds by
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heating a mixture of dimethyl titanocene and the carbonyl substrate in THF or toluene at 60-
750C. The scheme below shows our proposed route towards the synthesis of the diene [110].
a:H3 (i) ~3 (ii) ~J~ ~
(106] o OEt OEt
(157] (110)
The vinylogous urethane [157] was successfully synthesized from the thiolactam [106] and
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Figure 4 18 NMR spectrum of ethyl 2-(l-methyl-2-piperidinylidene)acetate [157] in
CDCh·
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In the carbon NMR spectrum the quaternary carbon as well as the carbonyl carbon signal
resonated downfield at 162 ppm and 169 ppm respectively (Figure 5). The vinyl carbon was
observed at 82 ppm. In the proton NMR the vinyl proton was observed as a singlet at 4.4 ppm,
all this clear evidence that the reaction did take place. The quartet and triplet corresponding to
the methylene and methyl protons (C9 and C IO) of the ethoxy group were observed at 1.1 ppm
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Figure 5 13C NMR spectrum of ethyl 2-(I-methyl-2-piperidinylidene)acetate (157) in
CDCh
Having synthesized the vinylogous urethane (157], it was then reacted with dimethyl
titanocene in THF at 60°C as proposed in Scheme 2.12. GCMS and TLC analysis showed only
the starting material so the temperature was increased to reflux, but still there was no sign of
any product being fonned. The solvent was changed to toluene and the mixture heated under
reflux but still there was no product was detected.
Due to time constraints and our failure to prepare the requisite diene, we then decided to focus
our attention and efforts towards achieving our second aim, the enantioselective synthesis of
the B and C rings offasicularin (13).
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CHAPTER 3
ENANTIOSELECTIVE SYNTHESIS OF THE B AND C RINGS OF FASICULARIN
To be discussed in this chapter is the stereoselective route towards the construction of the
spirofused B and C rings of fasicularin [13] (Scheme 1.12). Tills was a major goal of this
project. If the proposed methodology works, it will then be extended towards the syntheses of
the other perhydropyrrolo[2,1 j]quinoline and perhydropyrido[2,1-J"]quinoline alkaloids
discussed in Chapter 1. To be discussed in this chapter are the successes and failures incurred
en route to this goal.
3.1 (2S)-5-0xotetrahydro-2-furancarboxylic acid [123]
~2
[113)
Scheme 3.1 (i) NaN02, Hel, H20
(i)
[123)
The synthesis of the lactone [123] is well documented.60,61,62 We adapted the synthetic route
reported by Herdeis.6o Lactone [123] was synthesized from the commercially available and
optically pure (S)-enantiomer of glutamic acid [113]. Aqueous HCI was added to solution of
the glutamic acid [113] in water, followed by sodium nitrite. After overnight stirring the water
was removed by distillation. The resultant oil was supposed to form crystals but it did not.
Thus a minimum volume of chloroform was added and the flask was cooled to -30°C. White
crystals of analytically pure (2S)-5-oxotetrahydro-2-furancarboxylic acid [123J were formed in
51 % yield. Tills yield compared favourably to the 55% obtained by Herdeis.6o A melting point
of 70.8 - 72.0°C was recorded, which agreed favourably with the literature value (71_73°C)60,61
and GCMS showed a m/z value of 130. The next step was to reduce the carboxylic acid group
to a primary alcohol.
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3.2 (SS)-S-(Hydroxymethyl)dihydro-2(3H)-furanone[124J




(5S)-5-(Hydroxymethyl)dihydro-2(3H)-furanone [124J was synthesised from (5S)-5-
oxotetrahydro-2-furancarboxylic acid [123J using a procedure reported by Silverstein.61
Borane-methylsulfide complex was added to a solution of carboxylic acid [123J in THF. In
their procedure, after aqueous work up with methanol, the resultant oil was distilled. We
obtained better results when the crude product was purified by column chromatography. (5S)-
5-(Hydroxymethyl)dihydro-2(3H)-furanone [124J was obtained as a colourless oil in 82%
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Figure 6 lJC NMR spectrum of (SS)-S-(hydroxymethyl)dihydro-2(3H)-furanone (124J in
CDCh
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Figure 6 above shows the carbon NMR spectrum of the alcohol [124]. Downfield at 178 ppm is
the carbonyl signal, with the methine signal resonating further upfield at 81 ppm. The
disappearance of the C02H signa} further downfield and its replacement with the methylene at
64 ppm is an indication that the desired reaction has taken place. The primary alcohol [124]
was then converted into a mesylate.






The alcohol [124] was converted into mesylate [125] by treatment with methanesulfonyl
chloride and triethylamine in dichloromethane at -30°e. After aqueous workup with HCl the
residue was purified by column chromatography. The mesylate was chosen instead of the
tosylate because the tosyl derivative showed a marked lower reactivity towards sodium azide to
be used in the following step.60 (5S)-5-0xotetrahydro-2-furanyl]methyl methanesulfonate [125]
was obtained as light yellow oil in a 61 % yield. GCMS and NMR spectroscopic data showed
that the desired reaction had taken place and GCMS showed a m/z value of 194. The
appearance of a new signal at 37 ppm in the carbon NMR spectrum and a singlet at 3.0 ppm in
the proton NMR spectrum, both corresponding to the methyl group were clear evidence of the
formation of the product [125]. The mesylate [125] was then converted into the corresponding
azide.
3.4 (5S)-5-(Azidomethyl)dihydro-2(3H)-furanone [126]
Mesylate [125] was heated at reflux with sodium azide and 18-crown-6 in acetonitrile for 12
hours. After evaporation of the solvent the residual oily suspension was filtered through silica
gel using ethyl acetate as eluent.
O~r:~oso,CHJ
[125)





(5S)-5-(Azidomethyl)dihydro-2(311)-furanone [126] was obtained as a yellow oil in an 83%
yield. GCMS showed a m/z value of 141 corresponding to the mass of compound [126]. The
disappearance of the methyl signal at 37 ppm showed that the mesyl (S02CH3) group had been
cleaved. Further proof was the upfield shift of the methylene carbon (CH20S) from 68 ppm to










Ring expansion, achieved by catalytic hydrogenation of the azide [126] in methanol at 3.5bar
and 30°C for 4hours, using palladium on carbon catalyst, gave (5S)-5-hydroxytetrahydro-
2(1l1)pyridinone [127]. The catalyst was removed by filtration by passing the suspension
through Celite. After evaporation of the solvent the product was purified by column
chromatography. Pure (5S)-5-hydroxytetrahydro-2(1l1)pyridinone [127] was obtained as white
crystals in 61 % yield; mp 118.5-120°C (lit.62 120-121°C). The existence of the hydroxy group
will provide the synthetic handle to incorporate the thiocyanate moiety on the C ring of
fasicularin (13]. The table below serves to give a comparison of our l3C NMR data for the
hydrogenation product [127] with those reported by Huh and Thompson.62 As can be seen
there is favourable agreement between these data.
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Table 1. Comparison of our I3C NMR data for [127] with published values






In the proton NMR spectrum (Figure 7) the protons at the methylene carbon (C4) appear as a
multiplet from 1.8 ppm to 2.0 ppm, indicating that they both exist in a similar environment. In
contrast the protons at the methylene carbons C3 and C6 each have two distinct signals,
showing their diastereotopic nature due to the presence of the stereogenic centre at Cs. The two
C3 protons are each seen as a multiplet at around 2.3 ppm and 2.5ppm, while the C6 protons are
multiplets at 3.2 ppm and 3.5 ppm. Another signal seen is that of CD30H at 4.9 ppm. Finally
the N-H proton is seen as a broad signal at 7.5 ppm.
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Figure 7 In spectrum of (5S)-5-hydroxytetrahydro-2(1H)pyridinone (127) in CDJOn
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The carbon NMR spectrum shows the carbonyl carbon downfield at 174.6 ppm and the
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Figure 8 13C NMR spectrum of (5S)-5-hydroxytetrahydro-2(IH)pyridinone [127] in
CD30D
3.6 Attempted protection of (5S)-5-hydroxytetrahydro-2(IH)pyridinone [127]









These reactions included the conjugate addition of the lactam [127] to methyl-2-nonenoate
[117] (Scheme 3.6) and thionation of the carbonyl group. These failed reactions forced us to
face the difficult challenge of selectively protecting a secondary alcohol in the presence of a
secondary amide. Different methods were attempted to protect the secondary alcohol. The first
reaction was an attempt to protect the hydroxyl group as benzoate ester.
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Scheme 3. 7 (i) Pyridine, PhCOCI, rt
Lactam [127] was reacted with 1.5 equivalents of benzoyl chloride in excess pyridine.88
Unfortunately the benzoyl group went to both the nitrogen and oxygen atoms. Instead of
forming the desired lactam [158], amide [159] was fonned. In the carbon NMR the three
carbonyl signals at 165, 172 and 174 ppm were convincing evidence for the formation of










Herdeis reported the protection of (5S)-5-hydroxytetrahydro-2(lH)pyridinone [127J using
imidazole and tert-butyldiphenylsilyl chloride in DMF.64 We attempted the reaction using the
same conditions without success. We checked the melting point of the imidazole we were
using and found it matched the literature value and thus were reassured there was nothing
wrong with it. We suspected the problem lay with the solvent, DMF. We then modified the
procedure by using pyridine as both the base and the solvent. The reaction was successful and
to our delight (5S)-5-{[tert-butyl(diphenyl)silyl]oxy}tetrahydro-2(1H)-pyridinone [114] was
obtained as a colourless oil in a 69% yield. Our spectroscopic data were in agreement with
those reported by Herdeis.64 In the proton NMR spectrum the success of the protection reaction
was shown by the presence of the singlet at 1.06 ppm for the t-butyl group and the phenyl
protons resonated between 7.34 ppm and 7.66 ppm. The aromatic carbon signals were visible
in the range 128 to 136 ppm. Our spectroscopic data were in close agreement with those
reported by Herdeis. 64 as seen in Table 2 below.
Table 2. Comparison of selected I3C NMR data for [114] with published values
















Scheme 3.9 (i) Lawesson 's reagent, toluene, 2h reflux
The protected lactarn (114] was reacted with Lawesson's reagent to give the thiolactarn (160]
as yellow crystals in 96% yield. The formation of the thiolactarn was confirmed by GeMS and
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Figure 9 I H NMR spectrum of (5S)-5-{[tert-butyl(diphenyl)silyl]oxy}tetrahydro-2(lH)-
pyridinethione (160J in CDCh
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In the proton NMR spectrum (Figure 9) the diastereotopic protons at C4 are each seen as a
multiplet at 1.7 ppm and 1.8 ppm, while the C3 protons were observed as multiplets at 2.8 ppm
and 3.1 ppm. There was a larger difference in chemical shift values of the C3 hydrogens than
,
the C4 hydrogens. The multiplet at 3.2 ppm accounts for both C6 protons. The N-H proton
appeared further downfield at 9.0 ppm. The protecting group was still intact since the aromatic
and (-butyl signals were still evident in both the proton and carbon NMR spectra The l3C
NMR spectrum of the thiolactam [160] showed clearly the appearance of the thiocarbonyl
quaternary signal at 202 ppm while the carbonyl signal of the lactam precursor had disappeared
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Figure 10 I3C NMR spectrum of (5S)-5-{[tert-butyl(diphenyl)silyl]oxy}tetrahydro-2(lH)-
pyridinethione [160J in CnCI3
With the thiolactam [160J in hand our next goal was to protect the nitrogen atom.
3.8 Attempted N-alkylation of (5S)-5-{[tert-butyl(diphenyl)silyIJoxy}tetrahydro-2(lH)_
pyridinethione [160J
It is necessary to protect the nitrogen atom of the secondary thiolactam because the
Eschenmoser coupling reactions of tertiary amides produce higher yields of products in shorter
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times than secondary thiolactams under similar reaction conditions.53 Another problematic
feature when doing Eschenmoser coupling reactions on secondary thiolactams is that Z-
enarninones are produced which have incorrect geometry for the future Die1s-Alder reaction as







Therefore for the later construction of the A ring of fasicularin we thought it a good idea to use
methyl2-nonenoate [117J as it mimics the hexyl chain of the A ring offasicularin.
3.8.1 Attempted N-alkylation of 5-Uterl-butyl(diphenyl)siJyIJoxy}tetrahydro-2(1H)-












As has been said earlier, literature precedents for the conjugate addition of the lactam to
alkenes are found in the work of Michael and Gravestock (Scheme 1.16).54,57,65-67 Attempted
conjugate addition of the thiolactam [160] to methyl 2-nonenoate [117] was carried out at room
temperature in THF using a catalytic amount of sodium hydroxide as base (Scheme 3.11).
However the reaction failed and only starting materials were recovered. Attempts to improve
the synthesis by heating the reaction mixture under reflux and addition of greater than catalytic
amounts of NaOH failed to improve matters. TLC analysis showed only unreacted starting
material and there was no sign of any product. Changing the base to sodium hydride caused the
cleavage of the silyl ether and the only isolated products were, tert-butyldiphenylsilanol
(TBDPSOH) as well as unprotected lactam [127J. Whilst searching for an alternative route to
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N-alkylate the thiolactam a paper by Guama et al.?] was discovered. The thiolactam [160] was
reacted with methyl-2-nonenoate [117] using 18-crown-6 and potassium carbonate as base.
Unfortunately no matter how long the reaction mixture was stirred for, no product formed and
only starting materials were recovered.
Bearing in mind that our primary interest was in the construction of the B and C rings of
fasicularin, N-alkylation is in principle unnecessary as it introduces the molecular scaffold for
assembly of the A ring. Our second attempt involved simple benzylation of the nitrogen atom.
Our reasoning was that with the nitrogen atom suitably protected we would be able to couple
the thiolactam with bromoacetone in an Eschenmoser sulfide contraction reaction. We would
then attempt the preparation of the B ring of fasicularin and thereafter remove the benzyl group
by catalytic hydrogenation.
3.8.2 Attempted preparation of (5S)-I-benzyl-5-{[tert-butyl(diphenyl)silyl]oxy}-
tetrahydro-2(1H)- pyridinethione [161]
The thiolactam [160] was reacted with benzyl bromide and sodium hydride as base in THF. A











The proton NMR spectrum on its own could not tell us if the product had been formed or not.
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Based on further NMR analysis we discovered that the benzyl group had bonded to the sulfur
atom instead (Scheme 3.12). The S-alkylated product 2-(benzylthio)-5-{[tert-butyl-
(diphenyl)silyl]oxy}-3,4,5,6-tetrahydropyridine [162J was obtained as a light yellow oil in a
63% yield. In the proton NMR spectrum the C9 protons were each seen as separate doublets at
4.1 ppm and 4.2 ppm. The aromatic protons resonates between 7.21ppm and 7.70 ppm. The
absence of the thiocarbonyl signal in the carbon NMR spectrum at 202 ppm attested to the fact
that we had lost the C=S group (Figure 11). A signal at 164 ppm corresponded to the
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Figure 11 I3C NMR spectrum of 2-(benzyIthio)-5-{[tert-butyl-(diphenyl)siIyIJoxy}-3,4,5,6-
tetrahydropyridine (162J in CDCh
Considering our failed attempts to protect nitrogen using methyl-2-nonenoate (117J and benzyl
bromide we decided to opt for a simple unsubstituted acrylate.
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3.8.3 Methyl 3-[(5S)-5- ([tert-butyl(diphenyl)silyl] oxy}-2-thioxotetrahydro-l(2H)-
pyridinyl]propanoate [163]








Scheme 3.13 (i) NaOH (cat.), THF
Conjugate addition of the thiolactam [160] to methyl acrylate was carried out at room
temperature in THF using a catalytic amount of sodium hydroxide as base. This time the
reaction was successful. The N-alkylated thiolactam [163] was obtained as a colourless oil in a
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Figure 12 Iu NMR spectrum of methyl 3-[(5S)-5-{[tert-butyl(diphenyl)silyl]oxy}-2-
thioxotetrahydro-l(2H)-pyridinyl ]propanoate [163] in CDCh
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In the 13C NMR spectrum (Figure 12) the appearance of a new signal downfield at 172 ppm
corresponding to the ester functionality was observed and the thiocarbonyl signal at 201 ppm
was still present. A singlet at 3.7 ppm in the IH NMR spectrum corresponding to the methyl
group was obserVed. We were unable to rationalize why the conjugate addition thiolactam
[160] to methyl 2-nonenoate [117] did not work at all considering the success achieved by
Michael and Gravestock (Scheme 1.16).54,57,65-67 The next step was the Eschenmoser coupling
of the thiolactam [160] with bromoacetone.










Overnight reaction of thiolactam [163] and bromoacetone in acetonitrile gave the
corresponding S-alkylated bromide salt. Subsequent reaction with triphenylphosphine and
triethylamine afforded the vinylogous amide [164] in 53% yield. The IH and 13C NMR
spectrum were assigned with the aid of DEPT, COSY and GHSQC spectra. In the proton NMR
spectrum four singlets for Cs, C15, C I2 and C13 protons were observed at 1.04 ppm, 2.05 ppm,
3.67 ppm and 5.03 ppm respectively (Figure 13). The C3, CIO, C4 and C9 methylene protons
were assigned using the COSY spectrum. The diastereotopic C6 protons are seen as separate
multiplets at 3.1 ppm and 3.2 ppm. The methine C5proton resonates at 4.0 ppm and finally the
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Figure 13 ID NMR spectrum of methyl 3-[(5S)-5-{[tert-butyl(diphenyl)silyl]oxy}2-[(E)-2-
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Figure 14 13C NMR spectrum of methyI3-[(5S)-5-{[tert-butyl(diphenyl)siJyl]oxy}2-[(E)-2-
oxopropylidine] tetrahydro-2(1H)-pyridinyl]propanoate [164] in CDCh
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The carbon signals were assigned using DEPT and GHSQC spectra. The 3 quaternary carbons
at C2, Cll, and Cl4 were observed at 161 ppm, 172 ppm and 195 ppm respectively (FigureI4).
The thiocarbonyl peak at about 200 ppm is absent providing further proof of the success of the
reaction.
3.10 Attempted diene and azabicycle formation
Our aim was to synthesise l-amino-3-siloxy-l,3-butadiene (165), by treatment of vinylogous
amide [164) with KHMDS followed by the addition of TBSCI and react it in a Diels-Alder
reaction using phenyl vinyl sulfone as dienophile to afford azabicycle [166) (Scheme 3.15).
This was based on the favourable results reported by Rawal and co_workers.58,59,73-77 The diene
formation step (164-+165) is a one-pot reaction. The diene [165) can be used without further
purification according to Rawal. We decided to do the reaction (164 -+ 166) in one pot as we
were unsure of the stability of diene [165]. Thus, without purification, phenyl vinyl sulfone
was then added to the reaction mixture containing the putative amino siloxy diene [165].
TBDPSa ''O;l
~Me















Scheme 3.15 (i) KHMDS, THF (ii) TBSCl (iii) phenyl vinylsulfone
GCMS and NMR data clearly showed that the product obtained was not the desired azabicycle
but instead the vinylogous amide, 1-[(5S)-5- {[tert-butyl(diphenyl)silyl]oxy} tetrahydro-2(1 H)-
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piperidinylidene]propanone [167]. GCMS showed a m/z value of393, which was less than m/z
479 of the starting material. In both the proton and carbon NMR spectra there were fewer
signals than observed for the starting materiaL A, new signal in the proton NMR spectrum was
observed further downfield at 10.9 ppm corresponding to the hydrogen atom on nitrogen
(Figure 15). The structure was confmned by IH, l3C and DEPT NMR experiments. COSY and
GHMQC spectra proved invaluable for the unambiguous assignment of all the NMR signals.
NOESY experiments were carried out in an attempt to unambiguously assign the methylene
protons at C3 and C6 in the proton NMR. Figure 15 and 16 show the proton and carbon NMR
of the vinylogous amide [167]. In the carbon NMR spectrum two quaternary carbons were
observed similar to those of the starting material corresponding to C2 and CI4 The result was
not what we wanted, but as is the case with most scientific endeavours, constituted a very
important serendipitous discovery. As we discussed earlier on in section 3.8, secondary
thiolactams usually give Z-enaminones under forcing conditions. This result thus constitutes a
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Figure 15 I H NMR spectrum of 1-[(5R)-5-{[tert-butyl(dipbenyl)silyl]oxy}tetrabydro_
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Figure 16 l3C NMR spectrum of 1-[(5R)-5-{[tert-butyl(diphenyl)silyl]oxy}tetrahydro-
2(1H)- piperidinylidene]propanone (167) in CDCh
From the NOESY spectrum (Figure 17) we saw that irradiation of the vinyl proton at 4.9 ppm
showed an enhancement of the NH proton at 10.9 ppm and the methylene protons at C4 as well
as the methyl protons at C 1S • There was no correlation between the vinyl proton and the C3
protons, which would be expected if the compound existed as the Z-isomer, providing the
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Figure 17 NOESY spectrum of 1-[(5R)-5-{[tert-butyl(diphenyl)silyI]oxy}tetrahydro-
2(1H)-piperidinylidene]propanone [167] showing irradiation of the vinyl proton at 4.9
ppm
Irradiation of H-5 (Figure 18) showed correlation with some of the aromatic protons, the t-
butyl protons, the methylene protons at C4, the 6a proton as well as a small correlation to the
3b proton. This NOESY spectrum proved invaluable in the unambiguous assignment of the
diastereotopic protons at C3 and C6. The COSY spectrum was used to differentiate the C3
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Figure 18 NOESY spectrum of 1-[(5R)-5-{[terl-butyl(diphenyl)silyl]oxy}tetrahydro-
2(1H)-piperidinylidene]propanone [167] showing irradiation of the methine (H-5) proton
at 4.0 ppm.
Considering our failed attempt to synthesise azaspirocycle [166] we moved to our next goal,
namely the enantioselective synthesis of mesylate [116]. Mesylate [116] contains the structural
features necessary for the construction of the A ring of fasicularin (Scheme 1.12).
3.11 Synthesis of (3R)-I,3-nonanedioJ [131]
The synthesis of (3R)-1,3-nonanediol [131J from l-octyne [115J was reported by Kitching and
co-workers in their work on the synthesis of the components of the rectal gland secretion of
fruit flies.63 The synthesis begins with the formation of the Grignard reagent ethylmagnesium
bromide, synthesized from magnesium and bromoethane in ether. Ethylmagnesium bromide
was then used as base to deprotonate I-octyne (115] to give oct-I-ynylmagnesium bromide
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which on reaction with fonnaldehyde provided 2-nonyn-I-ol (128]. The alkyne was reduced












Scheme 3.16 (i) EtMgBr, CH20; (ii) LiAIH4; (iii) (-)-DET, Ti(OPrh, TBHP; (iv) Red-AI; (v)
Re!32.
In Sharpless epoxidation, allylic alcohols are converted to optically active epoxides in better
than 90% enantiomeric excess.89 Sharpless epoxidation has been used during the preparation of
a large number of natural products.89,90 Thus treatment of the allylic alcohol (129] with (-)-
diethyl tartrate, titanium tetraisopropoxide and tert-butyl hydroperoxide afforded epoxide
[130]. Since both (-) and (+)-diethyl tartrate are readily available either enantiomer of the
product could be prepared.90 Reduction of the epoxide (130] with Red-Al
{[(CH30CH2CH20hAlH2]Na}, afforded (3R)-1,3-nonanediol (131]. Unfortunately the optical
rotation and high resolution mass spectrum of the sample were not obtained as the sample had









Scheme 3.17 (i) TBSCl, Et~ DMAP (ii) MsCl, EtJN
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Molander and Ronn reported the selective protection of a primary alcohol in the presence of a
secondary alcohol using TBSCl/Et3N/DMAP, immediately followed by the mesylation of the
secondary alcohol using Et3NlMsCI, in their work on the total synthesis of cylindricine C
(Scheme 3.17).32
Close inspection of compound (131) and [116J in Scheme 3.18 reveals similarities with
compounds (39) and [41J in Scheme 3.17. Thus we attempted the synthesis of mesylate [116J









Scheme 3.18 (i) TBSCI, Etyv, DMAP (ii) MsCI, Et~
Fortuitously the protection of the two OH groups of the diol was accomplished in one pot. The
primary alcohol was selectively protected by the addition of TBSCI, Et3N and DMAP to give
the monoprotected alcohol. This was immediately followed by the addition of methane
sulfonyl chloride and Et3N to give (IR)-I-(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)heptyl
methanesulfonate [116] in quantitative yield.
The product was characterized by lH, l3C as well as 2D NMR spectroscopy. In the proton
NMR spectrum the formation of the product was confinned by the presence of the three
singlets, CIO, Cll which overlaps with the C9 triplet and the C\3 singlet. The COSY spectrum
was used to assign the other proton signals (Figure 19). Cl appeared as a triplet at 3.7 ppm and
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Figure 19 lH NMR spectrum of (IR)-I-(2-{(tert-butyl(dimethyl)sily]oxy}-ethyl)heptyl
methanesulfonate (116]
All carbon peaks were assigned unambiguously except for C7 and Cg which were assigned with
help from ACD labs,91 a computer program which simulates carbon and proton NMR spectra
(Figure 20). From the starting material there was only one methyl group corresponding to C9,
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Figure 20 l3C NMR spectrum of (lR)-1-(2-{(tert-butyl(dimethyl)silyl]oxy}-etbyl)heptyl
methanesulfonate (116]
Having synthesized mesylate [116], we intended to use it for the N-alkylation of lactam (114].
3.12 Attempted coupling of mesylate [116] with lactam [114]
Kibayashi and co-workers reported the synthesis of tricyclic lactam (99) from the mesylate
(98] in their work on the first total synthesis of lepadiformine [12] (Scheme 1.10).8 t-BuOK
was added to a solution of bicyclic lactam (98) in THF and the reaction mixture was stirred at
room temperature for 30 min, followed by aqueous workup and extraction with diethyl ether.








We intended to use the same method to synthesise the N-alkylated lactam [118a] (Scheme
3.20). We hoped an SN2 reaction between the lactam [114] and the stereodefined mesylate













Scheme 3.20 (i) t-BuOK, THF
The reaction was attempted using Kibayashi's method described above. Unfortunately only the
starting materials were recovered. Our system is different from the work reported by Kibayashi
and co-workers (Scheme 3.19). The essential difference between our reaction and Kibayashi's
is that their reaction is taking place intramolecularly. In our case, the amide and the mesylate
are different molecules, hence an intennolecular process. The failure of this reaction
unfortunately meant that we could not couple the C ring (114] to the scaffold for the A ring
[116] of our target alkaloid fasicularin [13].
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3.13 CONCLUSION
The route towards the synthesis of the marine alkaloid described in chapter 1 looked attractive
and appeared feaSible based on the literature precedents already discussed in chapters I, 2 and
3.
Unfortunately in practice our synthesis was thwarted at certain key steps. We discovered that
what works for one system does not necessarily mean it will work for another. To summarise
we were able to prepare the C ring of fasicularin enantioselectively. This was further modified
to serve as a scaffold for constructing the B ring of fasicularin. Attempted enolate fonnation
and trapping on oxygen was scuppered by competitive deprotonation at an alternative
nucleophilic position, namely the position ~ to nitrogen. The scaffold for the A ring was
prepared enantioselectively in a multistep synthesis. However the crucial N-C bond fonnation
that would link the C ring to the A ring precursor failed.
All is not doom and gloom as there are three noteworthy achievements that have emanated
from this project.
In summary the achievements of the projects are as follows:
.:. The successful enantioselective preparation of the C ring of fasicularin.
•:. The successful enantioselective preparation of the scaffold for constructing the A ring
of fasicularin.
•:. The discovery of a mild method for the preparation of secondary E-enaminones.
Suggestions for future work
.:. Different bases and solvents can be used for the SN2 reaction between the lactam [114)












.:. Development of an alternative route towards the construction of the diene {167], since
,




In conclusion, significant progress was made towards our goals and a number of novel




Flash chromatography was performed using either column chromatography with Merck silica
gel 60 (230-400 mesh; particle size 0.040-0.063 om) or by radial chromatography on a
chromatotron using Merck silica gel 60 PF254, containing gypsum. Thin layer chromatography
(TLC) was performed on Merck Aluminum sheets coated with silica gel 60 PF254 (layer
thickness 0.2mm), with visualization of the compounds by inspection under light (254/365nm)
and/or by exposure to iodine vapour and/or dipping in anisaldehyde stain.
IH and 13C NMR as well as 2D NMR experiments were recorded on a Varian Gemini 200
MHz and a Varian Unity-lnova 500 MHz spectrometer. COSY, GHMQC, GHSQC and DEPT
spectra were routinely recorded to facilitate the unambiguous assignment of NMR signal. For
NMR samples, CDCh was used as the solvent except for (5S)-5-hydroxytetrahydo-
2(IH)pyridinone [127] where CD30D was used. Spectra recorded in CDCh were calibrated
using solvent signal at 7.26 ppm for IH and 77.0 ppm for I3C, while IH and 13C spectra run in
CD30D were calibrated using the solvent signals. All chemical shift values are given in ppm
and coupling constants, J, are given in Hz. Spectroscopic data is only given for new
compounds. Abbreviations used: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet.
GCMS spectra were recorded on a Hewlett Packard (HP5988A) using a quadrupole mass
analyzer, while HRMS were recorded on a double-focusing Kratos MS 80RF mass
spectrometer at the Cape Technikon Mass Spectrometry Unit. Melting points were recorded on
a Kofler hot stage apparatus and are uncorrected. IR spectra were recorded with a Perkin Elmer
Spectrum One spectrometer as thin films between NaCI plates. The absorptions are reported in
wave number (cm-I) scale, in the range 400-4000 cm-I. A 700W National domestic microwave
oven was used for microwave reactions. Optical rotations were obtained on a Perkin-Elmer
polarimeter 241 at 589 om.
All solvents used for the reactions and preparative chromatography were distilled.
Tetrahydrofuran and diethyl ether were distilled from sodium/benzophenone; acetonitrile,
75
dicWoromethane and triethylamine from calciwn hydride; toluene from sodiwn; pyridine from
potassiwn hydroxide. -78°C temperatures were attained using dry ice-acetone bath. Great care
was taken to ensure moisture sensitive reagents were used under inert conditions. Thus
glassware was routinely heated under vacuwn and the vacuwn replaced with N2 gas.
Concentration or evaporation in vacuo refers to the removal of solvent under reduced pressure
(9 mmHg, 30-40°C) using a rotary evaporator. Yields are calculated from the immediate
synthetic precursor used.
4.1. Attempted preparation of the azaspirocycles [111) and (112)
4.1.1. I-Methyltetrahydro-2(1H)-pyridioone (104)
Sodium hydride (50% suspension in mineral oil, 5.80 g, 33.3 mmol) was added to a solution of
piperidin-2-one [102] (3.00 g, 30.3 mmol) and iodomethane (4.73 g, 33.3 nunol) in dry THF
(50 mL) at O°C. The resulting reaction mixture was allowed to warm to room temperature and
stirred overnight. The reaction was quenched with water (20 mL) and the organic components
extracted with ethyl acetate (3 x 20 mL). The organic phase was separated and dried over
MgS04, filtered and concentrated in vacuo. Purification by silica gel chromatography (ethyl
acetate) afforded 1-methyltetrahydro-2(lH)-pyridinone (2.26 g, 20.0 nunol, 66%) as a yellow




Smith et al. reported the synthesis of the thiolactams (105] and (106].79 Lawesson's reagent
(7.35 g, 18.2 mmol) was added to a solution of I-methyl-2-pyrrolidinone (103) (3.00 g, 30.2
mmol) in toluene (120 mL). The reaction mixture was heated under reflux for 2h and the
solvent was evaporated in vacuo. The resultant mixture was purified by silica gel
chromatography (50% ethyl acetatelhexane) giving I-methyl-2-pyrrolidinethione (105] as a
yellow oil (3.14 g, 27.3 mmol, 90%); Rf 0.47 (60% ethylacetatelhexane); m/z 115. The
spectroscopic data were in close agreement with those reported by Smith et af. 79
4.1.3. I-Methyltetrahydro-2(1H)-pyridinethione (106]
Lawesson's reagent (2.19 g, 5.42 mmol) was added to a solution of I-methyltetrahydro-2(1H)-
pyridinone (104) (1.02 g, 9.03 mmol) in toluene (40 mL). The reaction mixture was heated
under reflux for 2h and the solvent was evaporated. The resultant mixture was purified by
column chromatography (50% ethyl acetatelhexane) glvmg 1-methyltetrahydro-2-
(1H)pyridinethione as the yellow oil (1.00 g, 7.77 mmol, 86%); Rr 0.52 (60%
ethylacetatelhexane); m/z 129. The spectroscopic data were in close agreement with those





Bromine (35.4 mL, 691 mmol) was added dropwise to a stirred solution of water (160 mL),
acetone (50 mL, 0.68 mol) and glacial acetic acid (37 mL) at 65°C. The resultant solution was
diluted with cold water (80 mL), cooled in an ice bath to lOoC and made neutral by
portionwise addition of anhydrous sodium carbonate (80 g). The organic layer was separated
and dried over anhydrous CaCh. The remaining oil was distilled using a short path distillation
apparatus to afford bromacetone as a colourless oil (55.9 g, 408 mmol, 60%); b.p (28 - 30°C /9
mmHg) lit.72 (40-42°C /13 mmHg).
4.1.5. 1-(I-Methyl-2-pyrrolidinylidene)propanone [107]
o
Michael co-workers reported the synthesis of 1-(1-methyl-2-pyrrolidinylidene)propanone
[107].80 Our synthesis begins with the addition of bromoacetone (3.60 g, 26.0 mmol) to a
stirred solution of I-methyl-2-pyrrolidinethione [105] (1.50 g, 10.0 mmol) in dichloromethane
(15 mL). The reaction mixture was stirred overnight at room temperature. The volatiles were
removed under vacuum and the residue was dissolved in dichloromethane (30 mL).
Triphenylphosphine (3.41 g, 13.0 mmol) and triethylamine (2.70 mL, 19.5 mmol) were added
and the reaction mixture was stirred for 30 minutes. Water (50 mL) was added and the organic
product was extracted with ethyl acetate (3 x 50 roL). The product was purified by column
chromatography (60% ethyl acetate/hexane) giving 1-(1-methyl-2-pyrrolidinylidene)-
propanone as an orange-brown oil (807 mg, 6.24 mmol, 58%); Rr 0.13 (60%
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ethylacetatelhexane); m/z 139. The spectroscopic data were in close agreement with those
reported by Michael and co-workers.
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4.1.6. 1-(1-Methyl-2-piperidinylidene)propanone [108]
Bromoacetone (1.79 g, 12.8 mmol) was added to a stirred solution of I-methyltetrahydro-2-
(1H)pyridinethione [106] (1.50 g, 11.6 mmol) in acetone (10 mL). The reaction mixture was
kept in the fridge (4°C) overnight. The solvent was evaporated and the resulting salt was
dissolved in acetonitrile (40 mL) and then treated with triphenylphosphine (3.05 g, 11.6 mmol)
and triethylamine (1.77 mL, 12.8 mmol). The resulting reaction mixture was stirred for 30 min,
filtered and the solvent was evaporated. The resultant mixture was treated with ethyl acetate
and filtered again. The solvent was evaporated and purification by column chromatography
(60% ethyl acetatelhexane) gave 1-(1-methyl-2-piperidinylidene)propanone as a brown oil
(551 mg, 3.59 mmol, 31%); Rr 0.13 (60% ethylacetatelhexane); m/z 153. The spectroscopic
data were in close agreement with those reported by Leete and co-workers.94
4.1.7. Alternative method to 1-(I-methyl-2-piperidinylidene)propanone [108}
Bromoacetone (5.35 g, 39.1 mmol) was added dropwise to a solution of triphenylphosphine
(10.0 g, 38.1 mmol) in acetone (120 mL). The resulting mixture was heated under reflux for 45
minutes. The solution was cooled to ooe. The precipitate was filtered off and washed with
ether (3 x 20 mL). The resultant salt (675 mg, 2.12 mmol) was mixed with I-methyltetrahydro-
2(1H)-pyridinone [104] (200 mg, 177 mmol) and the mixture was heated in the microwave at
different power settings (low, med, med-low, high) but in each case only the starting materials
were recovered.
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4.1.8. Attempted diene formation.
4.1.8.1. Attempted silylation ofvinylogous amide [107]
THF (5 mL) was added into a dried flask and cooled to O°C. Diisopropylamine (0.14 mL, 1.1
mmol) was added followed by 1M solution ofbutyllithiwn in THF (1.17 mL, 1.17 mmol). The
reaction mixture was cooled to -78°C and 1-(1-methyl-2-pyrrolidinylidene)propanone [107]
(125 mg, 0.898 mmol) was added. The reaction was stirred for a 15min followed by the
addition of TMSCI (0.15 mL, 1.17 mol) and stirred for further 15min. The solvent was
evaporated and the residue was treated with cold hexane. The GCMS showed the starting
material. The reaction was repeated at a higher temperature (O°C) and left for a longer period
but still no product formed and only the starting material was recovered. The base was changed
to KH and NaB but these changes failed to produce the desired product.
4.1.8.2. Attempted acylation ofvinylogous amide [107]
l-(l-Methyl-2-pyrrolidinylidene)propanone [107] (lOO mg, 0.718 rnmol) was added to a
solution of acetic anhydride (0.14 mL, 1.4 mmol) and p-TsOH (411 mg, 2.16 mmol). The
solution was heated to 140°C. After 3h the solution was cooled to room temperature and
dicWoromethane (15 mL) was added. The resulting solution was washed with water (2 x 20
mL), 5% sodium carbonate (2 x 20 mL) and dried over MgS04• TLC analysis showed only the
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starting material and this was also confIrmed by the GCMS results. The reaction was repeated
using HCI04, K2C03 and CC4, the results were similarly fruitless.
4.1.8.3. Attempted alkylation ofvinylogous amide [107]
OMe
Sodium hydride (50% suspension in mineral oil, 38 mg, 0.79 mmol) was added to a solution of
1-(I-methyl-2-pyrrolidinylidene)propanone [107] (lOO mg, 0.718 mmol) and iodomethane
(0.05 mL, 0.8 mmol) in dry THF (5 mL) at O°C. The resulting reaction mixture was allowed to
warm to room temperature and stirred overnight. The reaction was monitored by TLC and no
product was formed, only the starting materials were recovered.
4.1.9. 1-(3-Ethyl-l-methyl-2- pyrrolidinylidene) propanone [151]
o
A mixture of the vinylogous amide [107] (50 mg, 0.36 mmol) and potassium hydride (144 mg,
3.59 mmol, 35% mineral oil suspension, washed three times with dry ether) in ether (5 mL)
was stirred at O°C for 0.5h. Ethyl iodide (1.5 mL, 19 mmol) was then added dropwise and the
stirring was continued for another hour. A drop of water was added cautiously and the mixture
was concentrated under vacuum. The reaction was quenched with water (20 mL) and the
organic components extracted with ethyl acetate (3 x 20 mL). The organic phase was dried
over MgS04, fIltered and concentrated in vacuo. PurifIcation by radial chromatography (30%
ethyl acetatelhexane) afforded 1-(3-ethyl-I-methyJ-2-pyrrolidinylidene)propanone as an
orange/brown (38 mg, 0.23 mmol, 64%); Rr 0.32 (60% ethyl acetate/hexane); Vmta (film)/cm-
I
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2972-2873 (C-H), 1703 (C=O), 1629 (C=C); bH (500MHz : CDCh) 0.93 (3H, t, J 7.3,
CH~H2), 1.22-1.29 (2H, m, CH3CH1), 1.68-1.71 (lH, m, CH2CHaHbCH), 1.74-78 (IH, rn,
CH2CHaHbCH), 2.02 (3H, s, COCH3), 2.79 (3H, s, NCH3), 3.23 (lH, t, J9.9, NCHoHb), 3.43-
3.48 (lH, q, J 10.0, NCHaHb), 3.70 (lH,t, J 8.2, CH2CH2CH) 4.87 (lH, s, C=CH); be
(l25MHz : CDCh) 12.16 (CH2CH3), 25.27 (CH2CH3), 25.39 (NCH2CH2), 30.51 (COGh),
32.99 (CHCH2), 45.08 (NCH3), 52.82 (NC1-h), 88.36 (C=CH), 169.85 (NC), 193.04 (CO);
m/z 167 (46%, M\ 145 (lOO), 139 (36), 72 (34) (Found: M\ 167.1302. C IOH17NO requires
167.1310).
4.1.10. 1-(3-Ethyl-l-methyl-2-piperidinylidene)propanone [152]
A mixture of the vinylogous amide [108] (200 mg, 1.31 mmol) and potassium hydride (530
mg, 13.1 mmol, 35% mineral oil suspension, washed three times with dry ether) in ether (5
rnL) was stirred at O°C for 0.5h. Ethyl iodide (5.50 mL, 68.1 mmol) was then added dropwise
and the stirring was continued for a further 0.5h. A drop of water was added cautiously and the
mixture was concentrated under vacuum. The reaction was quenched with water (20 mL) and
the organic components extracted with ethyl acetate (3 x 20 mL). The organic layer was
separated and dried over MgS04, filtered and concentrated in vacuo. Purification by radial
chromatography (30% ethyl acetate/hexane) gave 1-(3-ethyl-l-rnethyl-2-piperidinylidene)-
propanone as a yellow oil (220 mg, 1.21 mmol, 92%); Rf 0.43 (300!<l ethyl acetatelhexane); Vmax
(film)/cm- I 2922-2873 (C-H), 1667 (C=O), 1601 (C=C); bH (500MHz : CDCh) 0.98 (3H, t, J
7.4, CH3CH2), 1.40-1.50 (IH, m, CH3CHaHb and IH, m, CH2CHaHbCH), 1.59-1.65 (lH, rn,
CHaHbCH2CH), 1.74-1.77 (lH, m, CH3CHaHb), 1.66-1.71 (lH, rn, CH2CHaHbCH), 1.90-1.95
(IH, rn, CHJhCH2CH), 2.05 (3H, s, COCH3), 2.80 (3H, s, NCH3), 3.15-3.24 (lH, rn,
NCHaHb), 3.25-3.28 (IH, rn, NCHaHb); 3.88 (lH, br m, CH2CH2CH), 4.95 (lH, s, C=CH); be
(125MHz: CDCh) 12.01 (CH2CH3), 18.37 (CH2CH3) 26.65 (CH2CH2CH), 31.72 (COCH3),
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35.03 (CHCH2), 40.27 (NCH3), 52.13 (NCH2), 93.41 (C=CH), 168.11(C=CH), 193.05 (CO);
m/z 181 (52%, ~), 166 (100), 138 (82), 77 (70).
4.1.11. EthyI2-(I-methyl-2-piperidinylidene)acetate [157]
o O~
Ethyl bromoacetate (1.92 g, 11.5 nullol) and I-methyltetrahydro-2-(lH) pyridinethione (1.35 g,
10.5 nullol) were stirred in dichloromethane (10 mL) at room temperature overnight. When salt
formation was complete (by TLC analysis), triphenylphosphine (3.02 g, 11.5 mmol) and
triethylamine (1.59 mL, 11.5 mmol) were added, after which stirring was continued at room
temperature for 30min. The reaction was quenched with water (50 mL) and the organic
components extracted with ethyl acetate (3 x 50 mL). The organic phase was dried over
MgS04, filtered and concentrated in vacuo. Purification by silica gel chromatography (30%
ethyl acetate/hexane) afforded ethyl 2-(I-methyl-2-piperidinylidene)acetate as an
orangelbrown oil (1.73 g, 9.44 mmol, 90%); Rc 0.60 (50% ethyl acetate /hexane); Vmax
(film)!cm-1 2976-2867 (C-H), 1679 (C=O), 1144 (C(=O)-O), 1094 (C-N); DH (500MHz :
CDCi), 1.13 (3H, t, J 6.9, CH2CH3) 1.52 (2H, In, NCH2CH2) 1.67 (2H, rn, CCH2CH2), 2.70
(3H, s, NCH3), 2.96 (2H, 1, J 6.0, CCH2) 3.11 (2H, 1, J 6.4, NCH2), 3.95 (2H, q, J 6.9,
CHJCH3), 4.41(IH, S, CH); Dc (l25MHz : CDCh) 14.45 (CH2CH3), 19.64 (NCH2CI-h), 23.28
(CCH2CH2), 26.39 (CCH2), 39.60 (NCH3), 51.47 (NCH2), 57.75 (CH2CH3), 82.18 (CH),
162.32 (C=CH), 168.50 (CO); m/z 183 (49%, Ml, 138 (lOO), 111 (65), 110 (34).
4.1.12. Attempted Petasis methylenation
Dimethyltitanocene (0.34 g, 1.7 mmol) was added to a solution of vinylogous urethane [157]
(lOO mg, 0.546 mmol) in THF (20 mL). The reaction mixture was heated at 60°C overnight.
The solvent was evaporated and the residue was treated with pentane to precipitate titanocene
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oxide byproducts. The precipitate was filtered and the solvent was evaporated. TLC analysis
and GCMS showed only the starting material. There was no sign of the desired product. The
reaction was repeated at reflux temperature and for longer time period but the results were
similarly disappointing. Even on changing the solvent to toluene none of the desired product
formed, instead the vinylogous urethane was recovered.
4.2. Construction of the Band C rings of fasicularin
4.2.1. (2S)-5-0xotetrahydro-2-furancarboxylic acid [123J
A solution of NaN02 (16.9 g, 0.243 mol) in water (120 mL) was added dropwise to a mixture
of L-glutamic acid (29.4 g, 0.200 mol) in water (200 mL) and 2N HCI (120 mL) at O°e. The
resulting light yellow solution was stirred overnight. The solvent was evaporated and the
resulting mixture was diluted with ethyl acetate (250 mL) and dried over Na2S04. The solvent
was evaporated and a minimum volume of chloroform was added and the flask was cooled to
-30°C giving (2S)-5-oxotetrahydro-2-furancarboxylic acid as white crystals (13.3 g, 0.102
. rnmol, 51%); m.p (70.8-72.0°C, lit. 60,61 71-73°C); m/z 130.
4.2.2. (5S)-5-(Hydroxymethyl)dihydro-2(3H)-furanone [124J
A 5M borane-methylsulfide (l0. 7mL, 53.7 rnmol) solution in diethyl ether was added
dropwise to a solution of (2S)-5-oxotetrahydro-2-furancarboxylic acid [123J (6.35 g, 48.8
rnmol) in THF (50 mL). After stirring for a further 3h anhydrous MeOH (40 mL) was added
84
and the solvent was evaporated in vacuo. Purification by radial chromatography (4%
ethanol/chlorofonn) afforded (5S)-5-(hydroxymethyl)dihydro-2(3H)-furanone as a yellow oil
(4.65 g, 40.1 mmol, 82%); RrO.27 (10% methanol/chloroform); m1z 116.
4.2.3. [(2S)-5-0xotetrahydro-2-furanyl]methyl methanesulfonate [125]
Methane sulfonylchloride (5.72 mL, 72.8 mmol) was added to a stirred solution of (5S)-5-
(hydroxymethyl)dihydro-2(3H)-furanone (7.67 g, 66.1 nuDol) and triethylamine (10.1 mL,72.7
nuDO!) in dichloromethane (90 mL) at -30°C. The resultant solution was stirred for 5min at -
30°C and then at room temperature for 2h. The reaction was quenched with 0.5N HCl (25 mL)
and the organic components extracted with dichloromethane (3 x 50 mL). The organic layer
was separate~ washed with water, dried over Na2S04, filtered and concentrated in vacuo.
Purification by silica gel chromatography (60% ethyl acetate/hexane) afforded [(2S)-5-
oxotetrahydro-2-furanyl]methyl methanesulfonate as a colourless oil (7.83 g, 40.3 nunol,
61%); RrO.81 (60% ethyl acetate-hexane); m1z 194.
4.2.4. (5S)-5-(Azidomethyl)dihydro-2(3H)-furanone [126]
To a solution of [(2S)-5-oxotetrahydro-2-furanyl]methyl methanesulfonate (5.20 g, 26.8 mmol)
and 18-crown-6 (1.35 g) in acetonitrile (50 mL) was added sodium azide (2.49 g, 40.2 nunol).
The resultant suspension was heated at reflux temperature for 12h. The solvent was evaporated
and purification by silica gel chromatography (ethyl acetate) afforded (5S)-5-(azidomethyl)-
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A mixture of (5S)-5-(azidomethyl)dihydro-2(3H)-furanone (3.90 g, 27.6 mmol) and palladium,
10wt.%, on activated carbon (100 mg) in methanol (120 mL) was hydrogenated at 300kPa at
30°C for 4h. The solution was filtered through Celite and the residue washed with hot
methanol. The solvent was evaporated and purification by column chromatography (8%
methanol/cWoroform) afforded (5S)-5-hydroxytetrahydo-2(IH)pyridinone as white crystals
(1.95 g, 16.9 mmol, 61%); Rc 0.25 (10% methanol/cWoroform); m.p 118 - 120°C, lit.62 120-
121°C; m1z 115. The spectroscopic data were in close agreement with those reported by Hub
and Thompson.62
4.2.6. Attempted protection of (5S)-5-hydroxytetrahydo-2(1H)pyridinone [127]
4.2.6.1. I-Benzoyl-6-oxo-3-piperidinyl benzoate [159]
o 0
11 11UC-Q,o::u
Benzoyl cWoride (0.23 mL, 2.0 mmol) was added to the solution of (5S)-5-hydroxytetrahydo-
2(1H)pyridinone (150 mg, 1.30 mmol) in pyridine (lmL, dried over KOH overnight and
distilled). The resulting reaction mixture was stirred overnight. The reaction was quenched
with 3% HCI (20 mL) and the organic components extracted with ethyl acetate (3 x 20 mL).
The organic phase was washed with water, dried over MgS04, filtered and concentrated in
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vacuo. Purification by silica gel chromatography (5% ethyl acetate/hexane) afforded 1-
benzoyl-6-oxo-3-piperidinyl benzoate as white crystals (290 mg, 0.949 mmol, 690,10); Rf 0.88
(5% ethyl acetate/hexane); Vmar (film)/cm-
1 2976-2867 (C-H), 1715 (C=O), 1070 (C-N); bH
(200MHz : CDCh) 2.28-2.37 (2H, m, CHCHJCH2), 2.55-2.70 (lH, m, COCHaHb) 2.77-2.90
(1H, m. COCHJ/b), 3.90-4.01 (1H, m. NCHaHb), 4.18-4.27 (1H, m, NCHJ/b), 5.59-5.65 (1H,
m, CH), 7.35-8.08 (aromatic protons); Oe (50MHz: CDCh) 25.88 (CHCH2CH2), 30.40
(COCH2), 48.94 (NClh), 66.45 (CH), 127.92-135.42 (aromatic carbons) 165.42 (OCO),
172.14 (NCOAr); 174.02 (CH2NCOCH2); m/z 323 (2%, M), 201 (19), 105 (100), 77 (33).
4.2.6.2. (5S)-5-{[terl-Butyl(diphenyl)silyl]oxy}tetrahydro-2(lH)-pyridinone [114]
tert-Butyldiphenylsilyl cWoride (0.27 mL, 1.0 mmol) was added to the solution of (5S)-5-
hydroxytetrahydo-2(1H)pyridinone (100 mg, 0.869 mmol) in pyridine (2 mL, dried over KOH
overnight and distilled). The reaction was quenched with 3% HCI (50 mL) and the organic
components extracted with ethyl acetate (3 x 20 mL). The organic phase was washed with
water, dried over Na2S04, filtered and concentrated in vacuo. Purification by silica gel
chromatography (5% methanolldicWoromethane) afforded (5S)-5- {[tert-butyl(diphenyl)silyl]
oxy}tetrahydro-2(lH)-pyridinone as a colourless oil (212 mg, 0.600 mmol, 69%); Rf 0.74
(10% methanolldicWoromethane); [a]D23 -12 (chloroform); Vmax (film)/cm-
I 3071 (NH),2931-
2857 (CH), 1669 (C=O), 1112 (C-N), 1257 (SiC), 822 (SiO); bH (500MHz : CDCh) 1.06 (9H,
s, SiC(CH3h), 1.76-1.81 (lH, rn, CHCHaHb), 1.87-1.93 (lH, rn, CHCHJib) 2.24-2.30 (IH, rn,
CHCH2CHaHb,) 2.63-2.69 (IH, m, CHCH2CHJ/b), 3.20 (2H, d, J 11.3, NCH2), 4.08 (IH, d, J
3.7, CH), 6.18 (NH), 7.34-7.66 (aromatic protons); Oe (125MHz: CDCh) 19.13 (SiC(CH3)3),
26.82 (SiC(CH3)3), 27.33 (COCH2), 28.36 (CHClilCH2), 48.97 (NGil), 64.66 (CH), 127.77-
135.63 (aromatic carbons), 172.1 (C=O); m/z 354 (100%, (M+H)1, 199 (40), 137 (33), 135
(63) (Found: (M+Hf, 354.1894. C21H2SN02Si requires 354.1889).
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4.2.7. (5S)-5-{ [tert-Butyl(diphenyl)silyl)oxy}tetrahydro-2(lH)-pyridinethione [160]
Lawesson's reagent (0.688 g, 1.70 mmol) was added to a solution of (5S)-5-{(tert-
butyl(diphenyl)silyl] oxy}tetrahydro-2(1H)-pyridinone (1.00 g, 2.83 mmol) in toluene (40
mL). The reaction mixture was heated under reflux: for 2h and the solvent was evaporated in
vacuo. The resultant mixture was· purified by silica gel chromatography (30% ethyl
acetatelhexane) to yield 5- {[tert-butyl(diphenyl)silyl]oxy}tetrahydro-2(1H)-pyridinethione as a
yellow oil (1.00 g, 2.71 mmol, 96%); Rr 0.37 (30% ethyl acetatelhexane); [a]D23 -28
(chlorofonn); Vmax (film)/cm-
I 3071 (N-H), 2967-2851 (C-H), 1251 (SiC), 1156 (C=S), 1111
(C-N), 823 (SiO); OH (500MHz : CDCh) 1.06 (9H, s, SiC(CH3h), 1.68-1.74 (IH, rn,
CHCHaHbCH2), 1.77-1.83 (IH, m, CHCHaHbCH2), 2.81-2.87 (lH, rn, CSCHaHb), 3.10-3.18
(lH, m, CSCHaHb), 3.19-3.22 (2H, m, NCH2), 4.09-4.13 (lH, rn, CH), 7.35-7.65 (aromatic
protons), 9.01 (NH); Oc (125MHz : CDCh) 18.97 (SiC(CH3)3), 26.72 (SiC(CH3)3), 27.95
(CHCH2CH2), 35.57 (CSCH2), 51.03 (NCH2), 63.49 (CH), 127.52-135.47 (aromatic carbons),
202.09 (C=S); m/z 369 (2%, M\ 312 (100), 252 (63), 199 (49) (Found: ~, 369.1576.
C2I H27NOSSi requires 369.1583)
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Sodium hydride (50% suspension in mineral oil, 26 mg, l.1 mmol) was added to a solution of
thiolactam (340 mg, 0.920 mmol) and benzylbromide (1.31 mL, 1.10 mmol) in dry THF (50
mL) at O°C. The resulting reaction mixture was allowed to warm to room temperature and
stirred overnight. The reaction was quenched with water (20 mL) and the organic components
extracted with ethyl acetate (3 x 20 mL). The organic phase was dried over MgS04, filtered
and concentrated in vacuo. Purification by radial chromatography gave 2-(benzylthio)-5-{[tert-
butyl-(diphenyl)silyl]oxy}-3,4,5,6-tetrahydropyridine (266 mg, 0.579 mmol, 63%); Rr 0.45
(10% ethylacetate/hexane); [a]D29 - 44 (cWorofonn); Vmax (film)/cm-
I 2924-2853 (CH), 1494,
1453, 1234 (SiC), 829 (SiO); bH (500MHz : CDCh) 1.09 (9H, s, C(CH3)3), 1.73-1.79 (2H, m,
CHCH2CH2), 2.17-2.23 (lH, m, CHCH2CHaHb), 2.56-2.63 (IH, m, CHCH2CHaHb), 3.63-3.69
(2H, m, NCH2), 3.95-3.98 (lH, m, CH), 4.12 (IH, d, J 13.7, CSCHaHtAr), 4.24 (1H, d, J 13.7,
CSCHaHtAr), 7.21-7.70 (aromatic protons); &: (125MHz : CDCh) 19.17 (C(CH3)3), 26.89
(C(CH3)), 27.92 (CHCH2CH2), 28.89 (CHCH2CH2), 33.07 (CSCH2), 57.31 (NCH2), 65.87
(CH), 126.84-138.24 (aromatic carbons), 164.18 (CSCH2); m/z 459 (7%, M\ 199 (11), 135
(23), 91 (lOO).
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4.2.8.2. Attempted conjugate addition of the thiolactam [114] to metbyl-2-
nonenoate [117]
(i) Thiolactam [114] (100 mg, 0.271 mmol), methyl-2-nonenoate [117] (60 mg, 0.33 mmol)
and a catalytic amount of fmely crushed NaOH in dry THF (5 mL) were stirred overnight (a
mixture of the E- and Z-isomers of methyl-2-nonenoate [117] was synthesized by means of a
Wittig reaction between heptanal and ethyl bromo acetate). Based on TLC analysis the reaction
had not worked. Attempts to encourage the reaction by heating the reaction under reflux and
the addition of greater than catalytic amounts ofNaOH failed.
(ii) Another method was attempted: thiolactam [114] (lOO mg, 0.271 mmol) and K2CO:J (75
mg, 0.54 mmol) and 18-crown-6 (20 mg) were suspended in dry THF (15 mL). After being
cooled to O°C, methyl-2-nonenoate [117] (149 mg, 0.809 mmol) was added dropwise, the
reaction mixture was stirred at O°C for 5 minutes and then 1h at room temperature. The





A catalytic quantity of finely crushed NaOH was added to a solution ofthiolactam [114] (100
mg, 0.271 mmol) and methyl acrylate (0.05 mL, 0.5 mmol) in dry THF (3 mL). Water (15 mL)
was added and the organics extracted with ethyl acetate. The resulting reaction mixture was
stirred overnight at room temperature. The reaction was quenched with water (15 mL) and the
organic components extracted with ethyl acetate (3 x 20 mL). The organic phase was separated
and dried over MgS04, filtered and concentrated in vacuo. Purification by radial
chromatography (7% ethyl acetate/hexane) afforded a colourless oil (73 mg, 0.16 mmol, 59%).
This compound was used without further purification; Rr 0.36 (30% ethylacetate/hexane);
[0.]0
26 -15 (chloroform); Vmax (film)/cm-
1 2931-2856 (C-H), 1737 (C=O), 1260 (SiC),1112 (C-
N), 823 (SiO); OH (500MHz : CDCb) 1.06 (9H, s, SiC(CH3)3), 1.71-1.75 (2H, q, J 6.4,
CHCHJCH2), 2.66-2.71 (1H, m, NCH2CHaHb), 2.80-2.94 (IH, m, NCH2CHJ/b and IH, m,
CSCHaHb), 3.16-3.23 (lH, rn, CSCHJ/b), 3.32-3.40 (2H, rn, NCHJCH), 3.65 (3H, s, C~CH3),
4.00-4.10 (lH, m, NCHaHbCH2), 4.11-4.17 (lH, m, NCHaHbCH2 and IH, m, CH2CH), 7.38-
7.64(aromatic protons); Bc (125MHz : CDCb) 19.06 (SiC(CH3)3), 26.82 (SiC(CH3)3), 28.50
(CH2CH2CH), 30.23 (NCH2CH2), 38.21(CSCH2), 50.67 (NCH2CH2), 51.82 (C~a-h) 58.07
(NCH2CH),65.45 (CH2CH)' 127.87-135.62 (aromatic carbons), 171,99 (C02CH3) 199.74 (CS),




Bromoacetone (150 mg, 1.09 mmol) was added to a stirred solution ofmethyI3-[(5S)-5-{[tert-
butyl(diphenyl)silyl]oxy}-2-thioxotetrahydro-l (2H)-pyridinyl]propanoate [163] (lOO mg,
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0.219 mmol) in acetone (10 mL). The reaction mixture was kept in the fridge (4°C) overnight.
The solvent was evaporated and the salt was dissolved in acetonitrile (20 mL) and treated with
triphenylphosphine (300 rng, 1.14 mmol) and tr1ethylamine (0.15 mL, 1.14 mmol). The
resulting reaction mixture was stirred for 30 min. The reaction was quenched with water (15
mL) and the organic components extracted with ethyl acetate (3 x 20 mL). The organic phase
was separated and dried over MgS04, filtered and concentrated in vacuo. Purification by radial
chromatography (5% ethyl acetate/hexane) afforded methyl 3-[(5S)-5-{[tert-
butyl(diphenyl)silyl]oxy}2-[(E)-2-oxopropylidine]tetrahydro-2(1ll)-pyridinyl] propanoate as a
brown oil (58 mg, 0.12 mmol, 53%); Rr 0.23 (30% ethyl acetate/hexane); [a]D29 -3.6
(chloroform); Vma% (film)/crn-1 2953-2857 (C-H), 1737 (C=O), 1259 (SiC), 1112 (C-N), 822
(SiO); OH (500MHz : CDCb), 1.04 (9H, s, SiC(CH3)3), 1.61-1.69 (2H, rn, CCH~H2), 1.82-
1.87 (2H, rn, NCH2CH2), 2.05 (3H, s, COCH3), 2.49-2.58 (2H, m, CHCH~H2), 3.05-3.11 (IH,
m, NCHaHbCH), 3.16-3.19 (lH, m, NCHJ/bCH), 3.41 (2H, 1, J 7.3, NCH2CH2), 3.67 (3H, s,
C02CH3), 3.99-4.02 (IH, m, CH2Cll), 5.03 (IH, s, CCll), 7.36-7.65 (aromatic protons); Oc
(125MHz : CDCh) 19.31 (SiC(CH3)3), 24.19 (CHCH2CI-h), 27.10 (SiC(CH3)3), 28.01
(CCH2CH2), 30.34 (NCH2CH2), 31.96 (COCH3), 47.67 (NCH2CH2), 52.15 (C02CH3), 56.64
(NCH2CH), 66.26 (CH2CH), 93.33 (CCH), 128.02-135.89 (aromatic carbons), 161.41 (CCH),
172.01 (C02CH3), 194.56 (eaCH3); m/z 479 (51%, Ml, 436 (44), 218 (100), (Found: ~,
479.2488. C2sH37N04Si requires 479.2492).
4.2.10. 1-[(5S)-5-{[tert-Butyl(diphenyl)silyl)oxy} tetrahydro-2(1H)-piperidinylidene]-
propanone [167]
A solution ofKHMDS (62 mg, 0.32 mmol) in TIIF (2,mL) was cooled to -78°C. To the cooled
solution, was added vinylogous amide [164) (100 mg, 0.208 mmol). The temperature was
allowed to warm to O°C for 1h and then cooled to -78°C and treated with tert-
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butyldimethylsilyl chloride (48 mg, 0.32 mmol). The reaction mixture was allowed to wann up
to room temperature. The reaction mixture was cooled to O°C, and a solution of phenyl vinyl
sulfone (70 mg, 0.42 mmol) in THF (1 mL) was added. The reaction mixture was allowed to
wann up to room temperature and was allowed to stir overnight. The solvent was evaporated in
vacuo and purification was done using radial chromatography. 1-[(5S)-5-{[tert-
butyl(diphenyl)silyl]oxy}-2-piperidinylidene]propanone was obtained as a brown oil (59 mg,
0.15 mmol, 71 %); Rr 0.45 (40% ethyl acetatelhexane); [o.]D23 -62 (chloroform); Vnun
(film)/cm-I 3071(N-H), 2957-2857 (C-H), 1712 (C=O),1269 (SiC), 1112 (C-N), 822 (SiO); DH
(500MHz : CDCh) 1.06 (9H, s, SiC(CH3)3), 1.72-1.76 (2H, m, CHCH2CH2), 1.99 (3H, s,
COCH3), 2.18-2.24 (1H, m, CCHaHbCH2), 2.62-2.68 (IH, rn, CCHaHbCH2), 3.15-3.19 (IH, m,
NCHaHb), 3.24-3.27 (IH, m, NCHaHb), 4.03-4.07 (1H, m, CH2CH), 4.90 (1H, s, CCH), 7.37-
7.66 (aromatic protons), 10.92 (1H, s, NH); Dc (125MHz : CDCh) 19.11 (SiC(CH3)3), 25.23
(CCH2CH2), 26.85 (SiC(CH3)3), 27.67 (CHCH2CH2), 28.62 (COCH3), 47.75 (NCH2),65.30
(CH2CH), 93.23 (CCH), 127.74-136.64 (aromatic carbons), 163.15 (CCH), 194.27 (COCH3);
m/z 393 (8%, M), 352 (66), 336 (100, M'"-tert-butyl), 199 (26), (Found: M'", 393.21246.
C24H31N02Si requires 393.21241).
4.2.11. Synthesis of (3R)-I,3-nonanediol [131J
(3R)-1,3-Nonanediol [131J was synthesised in four steps from hept-l-yne [115] using the
procedure of Kitching and co-workers.63
4.2.12. (IR)-I-(2-{[tert-Butyl(dimethyl)silyIJoxy}ethyl)heptyl methanesulfonate [116J
Et3N (0.68 mL, 4.7 mmol) followed by TBSCI (564 mg, 3.74 mmol) and DMAP (12 mg) were
added to the solution of the (3R)-1,3-nonanediol (500 mg, 3.12 mmol) [131J in CH2Cb (5 mL).
The reaction mixture was stirred for 6 hours at room temperature. Additional Et3N (0.68 mL,
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4.68 mmo1) and MsC1 (0.29 mL, 3.7 mmo1) were added and the reaction mixture was stirred
for a further 3h. The solvent was evaporated and the residue dissolved in 30% ethyl
acetate/hexane. The crude mixture was filtere4 through a plug column. The solvent was
evaporated to give the mesy1ate [116] as a colourless oil (1.08 mg, 3.06 mmol, 98%); RrO.58
(50% ethyl acetate/hexane); Vmax (film)/cm-' 2928-2858 (C-H), 1733, 1225 (SiC), 1137, 1012;
DH (500MHz : CDCh) 0.04 (Si(CHj)2), 0.84-0.90 (9H, S, C(CHj)3 and 3H, m, CHjCH2), 1.26-
1.38 (4 x 2H, rn, CH3CH2CHJCH2CH2CH2CH), 1.71-1.75 (2H, m, CH2CHCH2CH20Si), 1.83-
1.88 (2H, rn, CH2CH20Si), 2.99 (3H, s, CHj0 2S), 3.70 (2H, t, J 6.4, CH20Si), 4.81-4.86 (lH,
m, CHOS); Dc (125MHz : CDCh) -5.20 (Si(CHjh), 14.24 (CfhCH2), 18.37 (C(CH3»), 22.76
(CH3CH2), 24.97 (CHCH2CH2CH2), 26.06 (C(CH3)3), 29.01 (CHCH2CH2CH2), 31.84
(CH3CH2CH2), 35.22 (CH2CHCH2CHzOSi), 37.44 (CHzCHzOSi), 38.43 (CH30 ZS), 58.88
(CHzOSi), 81.66 (CHOS).
4.2.13. Attempted coupling of mesylate [116] to lactam [115]
Mesylate [116] (260 mg, 0.737 mmol) and lactam (220 mg, 0.622 mmol) [115] were added to a
stirred solution of t-BuOK 1M (0.74 mL, 0.74 mmo1) in THF. The resulting mixture was
stirred at room temperature for 24 hours. There was no sign of the desired product even when
increasing the reaction time and temperature.
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